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ABSTRACT 
 
One of the most concerning characteristics of microbial biofilms is that of increased resistance to 
antimicrobial agents such as the commonly used biocide chlorhexidine (CHX).  This can have huge impact on 
clinical, household and environmental settings. This is particularly alarming when it involves opportunistic 
pathogenic environmental organisms such as Delftia acidovorans as routine mitigation practices may fail to be 
effective.  
 
This thesis examines tolerance mechanisms of D. acidovorans biofilms exposed to CHX at inhibitory and 
sub-inhibitory concentrations. To achieve the study goals and objectives, a CHX-tolerant D. acidovorans strain 
(WT15), (Minimum Inhibitory Concentration; MIC-15 µg ml-1) was compared to a CHX-sensitive strain (MT51, 
MIC-1 µg ml-1) that was obtained by mutating the wild type strain using transposon mutagenesis. Specific 
morphological, structural and chemical compositional differences between the CHX-treated and untreated biofilms 
of wild type and mutant strains were documented using microscopic techniques including confocal laser scanning 
microscopy (CLSM), scanning transmission x-ray microscopy (STXM), transmission electron microscopy (TEM) 
and infrared (IR) spectroscopy. Molecular level changes between biofilms formed by these two strains due to CHX 
treatment were compared using whole-cell proteomic analysis (determined using differential in-gel electrophoresis, 
or DIGE) along with fatty acid methyl ester (FAME) analysis. 
 
The gene disrupted by transposon insertion that led to increased susceptibility to CHX in the mutant strain 
was identified as tolQ. CLSM revealed differences in biofilm architecture and thickness between the biofilms 
formed by strains WT15 and MT51. STXM analyses showed that WT15 biofilms contained two morpho-chemical 
cell variants; whereas, only one type was detected in MT51 biofilms. STXM and IR spectral analyses revealed that 
CHX-susceptible MT51 cells accumulated the highest levels of CHX, an observation supported by TEM wherein 
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prominent changes in the cell envelope of CHX-susceptible MT51 cells were observed. DIGE analysis 
demonstrated that numerous changes in protein abundance occurred in biofilm cells following CHX exposure and 
that most of these proteins were associated with amino acid and lipid biosynthesis, protein translation, energy 
metabolism and stress-related functions. 
 
Overall, these studies indicate the probable role of the cell membrane and TolQ protein in CHX tolerance in 
D. acidovorans biofilms, in association with various proteins that are differentially-expressed. 
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1. INTRODUCTION 
The majority of bacteria in nature live attached to surfaces in structured multicellular communities referred 
to as biofilms (Costerton et al., 1995). They represent the sessile form of bacterial life versus a planktonic mode of 
existence. Biofilms have been associated with many persistent infections of humans and animals (Costerton et al., 
1999) and are a safety concern in the food industry (Wong, 1998). The root cause of the problems in industrial and 
medical settings due to biofilms is their ability to tolerate biocides, antibiotics, sanitising agents and host immune 
responses (Hoiby et al., 2010a). It has been demonstrated that some bacterial biofilms can be as much as 1,000 
times more resistant than their planktonic counterparts (Nickel et al., 1985; Tremblay et al., 2014). The 
mechanisms underlying antimicrobial tolerance in biofilms are not completely understood and hence a deeper 
understanding of them will help to develop compounds that can interfere with antimicrobial tolerance development 
and thus make biofilms susceptible to conventional, regularly used antimicrobial compounds.  Biofilm resistance to 
biocides could be an intrinsic trait of the microorganism or could be acquired, or both (Russell, 1995). Intrinsic 
resistance could be a result of the nature and composition of outer cell layers, spore formation, and phenotypic 
adaptation, including biofilm formation and the production of degradative enzymes (Morente et al., 2013). Genetic 
changes in a bacterial cell, either through mutation or by acquisition of extra-chromosomal elements such as 
plasmids or transposons, are molecular mechanisms of acquired resistance. 
Among the commonly available biocides, chlorhexidine (CHX) is a widely-used broad spectrum 
antimicrobial agent and an active ingredient in many disinfectants, antiseptics and pharmaceutical preservatives. 
Being a cationic bisbiguanide, it exerts its effect by reacting with the bacterial cell membrane causing leakage or 
coagulation of cytoplasmic constituents (Hope and Wilson, 2004). Several microorgansims have been found to be 
resistant to CHX (Stickler and Thomas, 1980; Stickler, 2002); however, the exact mechanisms of CHX resistance 
are still not completely understood. Penetration failure within biofilms, the permeability characteristics of the 
bacterial outer membrane (OM), CHX degradation, and the presence of resistance genes or plasmids have all been 
reported as possible causes for CHX resistance (Gilbert and Moore, 2005; Tanaka et al., 2005).  
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There are a number of food spoilage, pathogenic and environmental microorganisms that have been found 
to be associated with biofilms in food, medical, household and industrial environments. Delftia acidovorans, 
formerly known as Comamonas acidovorans and Pseudomonas acidovorans, is a Gram negative bacillus 
ubiquitously found in soil and water. Very little is known about the sessile form of D. acidovorans growth even 
though it has been occasionally associated with medical devices and water sources. Delftia acidovorans has been 
associated with several serious infections, including bacteremia, empyema, bacterial endocarditis, and ocular and 
urinary tract infections (Horowitz et al., 1990; Cho and Lee, 2002; Perla and Kuntson, 2005) and thus may be 
emerging as an opportunistic pathogen. Studies on the effects of antimicrobial agents on D. acidovorans biofilms 
are very limited; however, resistance of D. acidovorans to some of the commonly used antibiotics has been 
reported (Chun et al., 2009; Lipuma et al., 2011; Kam et al., 2012). 
Qualitative and quantitative data can be derived from biofilms using various currently available 
microscopic techniques. These techniques have been very widely used to study the interactions of antimicrobial 
agents with microbial biofilms (Mangalappalli-Illathu and Korber, 2006; Dynes et al., 2009; Tremblay et al., 
2014). Structure and formation of biofilms have been elucidated using various microscopic techniques like 
scanning and transmission electron microscopy. The application of confocal laser scanning microscopy (CLSM) 
has enabled the study of fully hydrated biofilms non-invasively and quantitatively. CLSM has the added advantage 
of being able to examine relatively thick biofilms by eliminating out-of-focus signals, allowing optical sectioning 
of biofilms and thereby the reconstruction of the 3D image of the entire biofilm structure (Lawrence et al., 1991). 
Major biomolecules of biofilms can be mapped using soft X-ray scanning transmission microscopy (STXM) 
(Lawrence et al., 2003). Speciation and distribution of metals and CHX have also been studied using this technique 
(Dynes et al., 2006a; Lawrence et al., 2012).  Correlative microscopic studies, where two or more methods are 
employed on the same sample, have enabled researchers to get further insights into antimicrobial interactions with 
biofilms (Lawrence et al., 2003; Dynes et al., 2009). 
Various proteomic and genomic studies have demonstrated the role of molecular mechanisms in bacterial 
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responses to antimicrobial agents. A number of genes are being added to the plethora of already reported genes that 
have been found responsible for biofilm formation and molecular adaptive mechanisms in various microbial 
species (Blair et al., 2015). Molecular adaptive mechanisms may act either singly or synergistically to confer 
resistance, the most commonly reported include those: i) resulting in persisters cells, ii) involved in stress response, 
iii) starvation and dormancy, iv) detoxification, v) altered permeability of the outer membrane and vi) active efflux 
of the agent (Blair et al., 2015). 
This thesis consists of two major studies that examined the mechanisms of CHX tolerance in Delftia acidovorans 
biofilms, and are entitled: 
(1) CHX tolerance in D. acidovorans biofilms - microscopic and spectroscopic analyses, and  
(2) Proteomic analyses of CHX tolerance in D. acidovorans biofilms  
The research work was based on the following hypothesis and techincal objectives 
 
1.1 Hypotheses 
There is a dearth of information related to mechanisms of CHX tolerance in bacterial species and 
particularly amongst the environmental species. In order to evaluate the possible mechanisms of CHX resistance in 
D. acidovorans biofilms, the following three hypotheses were considered for this research work. 1) CHX tolerance 
exists in environmental microorganisms such as D. acidovorans, and genetic status (or determinants) influences the 
susceptibility levels; 2) The cell membrane plays an important role in CHX tolerance in D. acidovorans biofilms 
and influences the uptake of CHX into the cell and structural/physiological effects thereon; 3) CHX tolerance in D. 
acidovorans biofilms is an interplay between several genes at the molecular level. 
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1.2 Technical objectives 
1. To screen a CHX tolerant strain of environmental D. acidovorans and to develop a screening assay to 
isolate a CHX-sensitive mutant strain that was mutated using transposon mutagenesis.  
2. To determine the gene or genes responsible for CHX tolerance. 
3. To evaluate structural and chemcial changes in CHX tolerant and CHX-susceptible D. acidovorans 
biofilms when challenged with CHX using microscopic and spectroscopic analyses. 
4. To examine the general stress response in D. acidovorans biofilms by comparing the proteomic state of 
CHX tolerant and CHX-susceptible strains when challenged with CHX. 
 
1.3 Organization of thesis 
This thesis is organized according to “manuscript-style” option of the College of Graduate Studies and Research. 
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2. REVIEW OF LITERATURE 
2.1. Biofilms 
The early twentieth century saw the emergence of studies focusing on living bacteria that grew on surfaces 
in the sessile state. Antonie van Leeuwenheok was the first to study surface-attached bacteria that were found on 
teeth plaque in 1684 (Rasmussen, 2000). The sessile growth of marine diatoms was first reported by Wilson (1925) 
and later in fresh water bacteria (Henrici, 1933). Many of the bacteria found in seawater would grow in a sessile 
state by attachment to a solid surface influencing their activity (Zobell, 1943). Microbes that grow on surfaces are 
commonly referred to as microbial biofilms. Microbial biofilms have been defined as populations of 
microorganisms that are attached to a solid substrate and typically surrounded by an extracellular polymeric 
substance (EPS) matrix (Costerton et al., 1978). It is generally assumed that complex biofilm communities may 
have developed from planktonic cells as a result of unfavourable conditions that existed in primitive earth. There 
are several lines of evidence regarding biofilm formation in the fossil record as early as approximately three billion 
years ago (Rasmussen, 2000; Westall et al., 2001). It is now well known that in a wide variety of natural habitats, 
the majority of microbes exist as biofilms (> 90% of microorganisms) and not as free-floating organisms 
(Costerton et al., 1995; 1999). 
 Advances in research techniques, which will be discussed later in this chapter, have shown that biofilms 
are not simply a group of cells that are attached to surfaces, but are structurally- and dynamically-complex 
biological systems with substantial benefits to the community, for example, being 10 to 1000 times more resistant 
to stress than their free-existing counterparts (Mah and Toole, 2001; Hoiby et al., 2010a). The EPS matrix in which 
the biofilm cells are aggregated consists of macromolecular components such as (primarily) polysaccharides, 
proteins, lipids, and extracellular DNA. This matrix plays an important role in the formation and maintenance of 
the biofilm structure and in defense mechanisms by protecting the cells from antimicrobial agents and host 
defenses in medical biofilms (Sutherland, 2001; Branda et al., 2005; Ryder et al., 2007). Apart from these two 
altered phenotypic differences (i.e., decreased susceptibility to antibiotics and predator/phagocyte tolerance) 
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between the bacterial aggregates and their planktonic counterparts, another density-dependent trait is bacterial cell-
to-cell communication, known as quorum sensing (Fuqua et al., 1994; Davies et al., 1998). Quorum sensing (QS) 
is a system wherein bacteria sense signal molecules that are produced proportional to the density of cells located on 
the surface, and thereby initiates the expression of QS-regulated genes. Virulence and antibiotic tolerance have 
been found to be regulated by QS (Latifi et al., 1995; Bjarnsholt et al., 2005).  
The occurrence of biofilms in hospital, marine, agricultural, industrial and food environments are a well-
known phenomenon wherein multi-species biofilm communities predominate. Medical biofilms associated with 
acute infections have been extensively studied and reported (Costerton et al., 1999; Donlan and Costerton, 2002). 
These acute infections caused by biofilm forming bacteria are more difficult to treat and so can develop into a more 
chronic disease state. Single species biofilms have been reported in hospital-related infections and medical devices 
and implants (Donlan and Costerton, 2002). Pseudomonas aeruginosa is the model organism used in many 
microbial biofilm-related studies. In human beings, biofilms formed by P. aeruginosa have been commonly 
associated with cystic fibrosis (Hoiby, 1974; 2002; Hoiby et al., 2010b). Other infections associated with biofilm 
forming bacteria are periodontitis, chronic wounds, otitis media, endocarditis, and urinary tract infections. Biofilms 
may also cause persistent contamination of medical fluids in devices such as dialysis machines, venous catheters, 
dental water lines, contact lenses, airway ventilators, and indwelling devices such as prostheses and heart valves 
(Donlan and Costerton, 2002).  Some other classic examples of environmental biofilms that are usually composed 
of multiple bacterial species include those found in drinking water lines, oil pipelines, wastewater treatment plants, 
the rhizophere, dental plaque, and human intestine and urinary systems (Donlan and Costerton, 2002; Parsek and 
Fuqua, 2004; Srey et al., 2013). When cells are shed from biofilms into the overlying liquid, contamination of 
drinking water and subsequent entry into the food chain may result.  Biofilms are a major source of food safety 
concerns in various food industries as they render microbes of concern resistant to routinely used cleaning 
chemicals (Srey et al., 2013). 
Biofilm formation is a very complex process and is an outcome of several physiological and genetic factors. 
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Davey and O'Toole (2000) have summarized the stages of biofilm development, and include: initiation, maturation, 
maintenance and dissolution. Hydrodynamic conditions of the surrounding flowing media, such as laminar and 
turbulent flow, have been shown to influence biofilm structures and alter these in response to changing flow 
conditions (Stoodley et al., 1999; Davey and O’Toole, 2000). Biofilms grown under laminar flow conditions were 
found to be patchy, consisting of cell aggregates separated by interstitial voids; whereas, the unique characteristic 
of biofilms grown in turbulent flow was the presence of elongated “streamers” that oscillated in the bulk fluid. 
Nutrient availability (e.g., type of carbon source, osmolarity of the medium, etc,) and the type of abiotic surface 
(stainless steel, glass, PVC, etc.) can also influence biofilm formation (O’Toole and Kotler, 1998), creating 
variations from the “mushroom” model to flat, homogenous structures (Klausen et al., 2003). Certain attachment 
surfaces can be rough or irregular (e.g., water pipes) while others can be smooth (e.g., catheters). Apart from the 
characteristics of the substratum, the nature of the bacterial cell surface can also play an important role in biofilm 
initiation and attachment. Cellular appendages such as flagella, pili, and fimbriae have been shown to facilitate 
microbial attachment to varying degrees (Rosenberg et al., 1982; Korber et al., 1989).  
Several researchers have carried out a variety of studies on biofilms growing in aquatic habitats like 
freshwater, streams, rivers, etc. (Neu and Lawrence, 1997; Manz et al., 1999; Battin et al., 2003; Lawrence et al., 
2004; Rickard et al., 2004; Lawrence et al., 2005) and also by using laboratory media (Korber et al., 1994; Anderl 
et al., 2000; Purevdorj et al., 2002). These include studies on the structure and pattern of biofilms formed, types of 
microorganisms involved, fluid dynamics, impact of nutrients, antibiotics, biocides and effects of other 
environmental factors such as pollutants.  A variety of model systems may be used to cultivate microbial biofilm 
communities including chemostats, nutristats, gradostats, flow cells, rotating annular bioreactors or the microstat 
(Caldwell et al., 1997). 
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2.2. Delftia acidovorans  
Delftia acidovorans is a Gram negative, aerobic, non-fermentative, non-spore forming, motile bacillus, 
ubiquitously found in soil and water. It has also been isolated from animal sources, food, activated sludge, hospital 
equipment and human clinical specimens. It was named after the city of Delft, Netherlands, the site of the initial 
isolation of the type species (Wen et al., 1999).  It belongs to the family Comamonadaceae under the β subclass of 
the Proteobacteria. It has been known as both Comamonas acidovorans and Pseudomonas acidovorans. In 1999, it 
was renamed as D. acidovorans based on rRNA relatedness studies and is currently classified in the Pseudomonas 
rRNA homology group III (Wen et al., 1999).  The cells are straight to slightly curved rods (0.4-0.8 x 2.5-4.1 µm) 
and occur singly or in pairs (Wen et al., 1999).  
Generally, D. acidovorans has received little attention compared to bacteria such as other Pseudomonas 
species and Escherichia coli, and relatively little is known about its pathogenicity, prevalence, health and 
environmental risks, genetic information, antibiotic resistance profile and resistance mechanisms. The reason for 
the paucity of data is unknown but it may be suggested that the Comamonads were previously classified as 
Pseudomonads and were not studied or reported separately. The first detailed report of the association of this 
organism with a clinical infection and its identification as a pathogen appeared when it was isolated from a case of 
endocarditis in a 42-year old intravenous drug abuser (Horowitz et al., 1990). Since then, reports of D. acidovorans 
association with a number of other serious infections, including bacteremia, empyema, bacterial endocarditis, 
ocular and urinary tract infections (del Mar Ojeda et al., 1999; Cho and Lee, 2002; Perla and Kuntson, 2005) have 
been increasing, thus establishing this organism as an emerging opportunistic pathogen. Delftia acidovorans has 
also been implicated in many infections associated with hospital devices like vascular catheters (Ender et al., 1996; 
Kawamura et al., 2011), pressure-monitoring devices (Weinstein et al., 1976) and surgical instruments (Mino et 
al., 2000) as a consequence of surface growth. Delftia acidovorans has also been isolated from contaminated water 
sources (Stiegler et al., 2003; La Duc et al., 2004). Interestingly, D. acidovorans was also named as one of the 
bacterial agents transmitted from fish used as food, or by fish-handlers, thus establishing its presence in the food 
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industry as well (Novotny et al., 2004).  
Delftia acidovorans is often resistant to aminoglycosides, a class of drugs commonly used to treat Gram-
negative bacterial infections, but usually susceptible to broad-spectrum cephalosporins, trimethoprim-
sulfamethoxazole, fluoroquinolones, and tetracycline (Chun et al., 2009; Lipuma et al., 2011). A D. acidovorans 
strain that caused keratitis in a patient showed slow response to vancomycin and amikacin but was successfully 
treated with ceftazidime (Lee et al., 2008). Delftia acidovorans isolated from a urinary tract infection was only 
susceptible to cefoperazone/sulbactam, imipenem, and doripenem but was resistant to all aminoglycosides, 
quinolones, as well as third- and fourth-generation β-lactam antibiotics (Kam et al., 2012). In this report, they 
cautioned regarding future threats from the emerging resistance to antimicrobial agents of this not-so-common 
human pathogen. Similarly, different antimicrobial susceptibility profiles of D. acidovorans were also observed by 
Kawamura et al. (2011) wherein it was shown to be resistant to broad spectrum penicillins and cephalosporins but 
susceptible to ceftazidime, carbapenems, ciprofloxacin, minocycline, and trimethoprim–sulfamethoxazole. Khan et 
al. (2012) demonstrated the importance of proper identification of the Delftia species and their antibiotic resistance 
profile when an infection caused by an aminoglycoside resistant strain of D. acidovorans proved to be fatal. β-
lactam resistance in D. acidovorans was found to be associated with β-lactamase production and alteration of outer 
membrane (OM) proteins (Ravaoarinoro and Therrien, 1999). Xu et al. (2007) characterized class 3 integrons from 
two environmental strains of Delftia spp. linking them to horizontal transfer of antibiotic resistance genes in the 
environment. 
In recent times this bacterium has become a topic of interest when it was demonstrated that a secondary 
metabolite produced by D. acidovorans (delftibactin A) can protect against the toxic form of gold by binding and 
causing its biomineralisation (Johnston et al., 2013). Another useful characteristic of D. acidovorans that has been 
well studied and exploited for environmental applications is its aniline-degrading capacity (Urata et al., 2004). 
Aniline is a known environmental toxin and carcinogen that is used in the synthesis of herbicides and dyes and 
often released into the environment (Lyons et al., 1985). Enzymatic degradation of xenobiotic compounds like 
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chlorinated phenoxyalkanoate herbicides (Yoon et al., 2014) and resistance to high concentrations of these 
chemicals have also been demonstrated (Muller and Babel, 2004; Roland and Wolfgang, 2004). Biotransformation 
of selenium, lead and the toxic form of chromium ions by Delftia species have also been recently reported making 
them good candidates for cleaning up environmental pollutants (Ubalde et al., 2012). A commercial biofertilizer 
formulation containing D. acidovorans is also available owing to its putative ability to oxidize sulfur (www. 
brettyoung.ca). 
 
2.3. Chlorhexidine  
According to the European Commission and European Chemicals Agency, 2014 “biocides are chemicals 
used to suppress organisms that are harmful to human or animal health, or that cause damage to natural or 
manufactured materials. These harmful organisms include pests and germs (i.e. moulds and bacteria). Examples of 
biocidal products are insecticides, disinfectants and industrial chemicals like anti-fouling paints for ships and 
material preservatives”. Some types of biocides have been used for a century or more (e.g., alcohol) whereas others 
have been introduced only recently (orthophthaladehyde). Biocides have been used for clinical, pharmaceutical, 
cosmetic and preservation purposes. Among the popular biocides used in recent times is chlorhexidine. CHX is a 
broad-spectrum biocide used mainly in hospital, veterinary and household applications. CHX was initially 
developed by Imperial Chemical Industries, England, during the 1940’s (Lindhe et al., 2003). Later, in 1954, 
Davies et al. (1954) further modified the structure of the compound to improve its bactericidal properties. This 
resulted in 1,6 bis-4 chloro-phenlydiguanidohexane, a cationic bisbiguanide commonly referred to as CHX. It 
consists of two symmetric 4-chlorophenyl rings and two biguanide groups connected by a central hexamethylene 
chain. CHX is available as diacetate, gluconate and hydrochloride salts. It is more effective at alkaline pH and its 
activity is greatly reduced in the presence of organic matter (Russell and Path, 1986). The chemical structure of 
CHX is given below (Figure 2.1). 
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Figure 2.1 Structure of chlorhexidine (adapted from http://en.wikipedia.org/wiki/Image: Chlorhexidine.png) 
 
Since the 1950’s, CHX has been a popular, widely used biocide with a range of applications and is 
considered as the gold-standard antimicrobial agent against which other antimicrobial and antiplaque agents are 
assessed (Jones, 1997; Mathur et al., 2011). CHX is presently an active ingredient in many commercially available 
disinfectants, antiseptics and pharmaceutical preservatives and is also listed in the World Health Organisation’s list 
of essential medicines for basic health (http://www.who.int/medicines/ publications/ essentialmedicines/en/). It has 
found very wide applications as an antiplaque agent in oral hygiene products and is used extensively in dental 
therapy. CHX is commercially available at a variety of concentrations (0.5%–4%) and formulations and certain 
CHX-containing products are available over the counter (Milstone et al., 2008). Based on their findings, Ugwumba 
et al. (2014) recommended the use of 0.2% CHX before dental extraction to reduce the risk of bacteraemia 
following dental extraction. Mouthwashes at 0.2% CHX also have a very effective antimicrobial effect on the 
salivary microflora (Addy et al., 1991; Jenkins et al., 1994) and dental plaque (Netuschil et al., 1989). The 
American Heart Association (Dajani et al., 1997) and the British Society for Antimicrobial Chemotherapy (Gould 
et al., 2006) also recommend the use of CHX-containing mouthwashes at 0.2% to prevent dental infections. CHX 
usage at 0.12 % killed 98.5% of Gram negative non-fermentative bacteria in dental unit water lines (Kotaka et al., 
2012). Other non-dental applications include general skin cleansing, as a surgical scrub, gynecological antiseptic, 
wound disinfectant and as a pre-operative skin preparation. It is widely used as a preservative in eye formulations 
and contact lens solutions (Russell and Path, 1986). It is also found in chewing gums, toothpastes, varnishes and 
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periodontal dressings (Othman et al., 1989; Smith et al., 1995) and as teat disinfectants for use on dairy farms 
(Tremblay et al., 2014). Landelle et al. (2014) recently reviewed the reduction of multidrug-resistant organisms 
(MRDO’s) in intensive care units by CHX body washing of patients but also cautioned that vigilance is required 
for emerging CHX resistance. Edmiston et al. (2013) demonstrated that CHX is a very effective agent to inhibit or 
kill skin microflora and that a 1 min exposure to 0.05% CHX produced a > 5 log reduction in hospital associated 
pathogens and reduced biofilm formation on implantable medical devices.  
CHX is bacteriostatic at low concentrations to many Gram positive and Gram negative bacteria and is 
bactericidal at higher concentrations, has antifungal properties, but is not sporicidal (Russell and Path, 1986). 
Despite its broad use, the exact mode of action of CHX remains unclear (Jones, 1997; Condell et al., 2014). 
Nonetheless, like any other cationic antimicrobials, the general mechanism of action of CHX involves the bacterial 
cell membrane (Gilbert and Moore, 2005) and it is a potent membrane-active agent. CHX is a positively-charged, 
hydrophobic and lipophilic molecule and can interact with bacterial cell membrane components such as 
phospholipids and lipopolysaccharides. CHX possesses broad antibacterial and antifungal activity and seemingly 
exerts its effect by reacting with negatively-charged groups on the cell surface, altering the integrity of the bacterial 
cell membrane and activity of membrane-bound enzymes thereby causing an irreversible loss of cytoplasmic 
constituents, as well as membrane damage. At high concentrations (2%), CHX causes extensive cell damage, 
increasing the permeability of the inner membrane, coagulation of cytoplasmic constituents, and precipitation of 
proteins and nucleic acids (Hope and Wilson, 2004; Cheung et al., 2012; Morente et al., 2013). Several factors 
affect biocidal activity of CHX, most notably concentration, period of contact, pH, temperature, the presence of 
interfering materials, and the types, numbers, location and condition of microorganisms (Russell, 2003); however, 
optimal antimicrobial activity can be achieved within a pH range of 5.5-7.0 (Athanassiadis et al., 2007). 
Morphological effects and structural damage of CHX on cell wall and cellular constituents have been reported by 
several research groups (Tattawasart et al., 2000a,b; Shalamanov, 2005; Cheung et al., 2012). 
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2.3.1. Chlorhexidine resistance in microorganisms  
According to the Centers for Disease Control and Prevention, microbial resistance to antibiotics is 
perceived as representing an increasing threat to public health over the past several years. Some scientists suggest a 
similar situation exists with regard to the wide application of various biocides in daily use in households, hospitals, 
industry and the environment (Gilbert and McBain, 2003). Despite the use of many biocides for many years, there 
have been no reports of environmental outbreaks of such resistance; however, experts believe biocide resistance 
may eventually emerge on a large scale. Continuous overuse and resultant potential selective pressure could lead to 
increased tolerance to different classes of biocides and also more dramatically, the emergence of cross-resistance to 
various clinically-important antimicrobial compounds (Fraise, 2002; McBain et al., 2002). However, several 
studies have demonstrated that there is no correlation between reduced susceptibility to biocides and resistance to 
clinically-relevant antimicrobial agents (Walsh et al., 2003; Condell et al., 2012). Though Thomas et al. (2000) 
demonstrated that repeated exposure to a sub-inhibitory concentration of CHX led to stable increases in the MICs 
of P. aeruginosa to chlorhexidine. An extensive study by Block and Furman (2002) involving different groups of 
organisms demonstrated an inverse correlation between the intensity of CHX use and the susceptibility of the 
organisms to CHX. 
Resistance is the relative susceptibility of a microorganism to a particular treatment under a particular set of 
conditions. For antibacterial agents, it is commonly quantified in terms of the minimum concentration required to 
inhibit the growth of a population of cells, termed the MIC (Gilbert and McBain, 2003). On the other hand, a 
microorganism is said to be resistant to a biocide when it is not inactivated by an in-use concentration of a biocide, 
or a biocide concentration that inactivates other strains of the same organism (Russell, 2003). Although several 
microbes have been reported to survive in the presence of in-use concentrations of CHX (Marrie and Costerton, 
1981; Stickler et al., 1987; Brooks et al., 2002), little is known about the underlying mechanisms for this tolerance. 
Resistance to biocides is often referred to as tolerance (Favero, 2002), since biocides usually have multiple targets 
and their efficacy is measured in terms of their rapidity to kill microorganisms. In simple terms, Cerf et al. (2010) 
 14 
proposed that the terms “resistance” should be used when the phenomenon being studied is killing and “tolerance” 
when it is used in reference to adaptation to inhibitory concentrations. There is no fixed minimum inhibitory 
concentration (MIC) value for CHX. It varies depending on the type of bacterial strain, phenotypic and genotypic 
status of the organism and the environmental conditions. Walker and Lowes (1985) found that MIC testing was 
unreliable in the assessment of CHX resistance as it was dependent on the medium used, the age of the culture, and 
size of inoculum indicating that CHX resistance is a complex phenomenon which is difficult to evaluate. Russell 
and Day (1993) indicated that as a general rule, CHX inhibits Gram positive and Gram negative bacteria at 
concentrations of 1 µg ml-1 and 2-2.5 µg ml-1, respectively.  
MIC values of a P. aeruginosa strain recommended for disinfectant testing and an industrial strain were 
found to be 60-85 µg ml-1 and 35-45 µg ml-1, respectively (Lear et al., 2006). The MIC for CHX of many of the 
strains isolated from the skin of patients undergoing intermittent bladder catherization proved to be 200-800 µg ml-
1 compared with the 10-50 µg ml-1 level recorded for reference strains of Gram negative bacteria (Stickler, 2002). 
In a recent study (Kishk et al., 2014), the MIC’s of 1% CHX for 56 Klebsiella pneumoniae strains isolated from 
human blood specimens ranged from 4 to 256 mg l-1. Koljalg et al. (2002) conducted CHX susceptibility testing of 
70 distinct clinical isolates including Pseudomonas spp. and found that non-fermentative bacteria tolerated CHX at 
higher concentrations and Gram positive cocci, especially Streptococcus pyogenes, were the most susceptible. 
Gram negative bacteria had a wider range of MIC values (1-64 mg l-1) than Gram positive bacteria (0.25-8 mg l-1). 
Pseudomonas stutzeri and P. aeruginosa became increasingly resistant to CHX when exposed to gradually-
increasing concentrations of the biguanide. The MIC’s increased from 2.5 to 50 mg l-1 and 10 to 100 mg l-1, 
respectively, within 12 days (Tattawasart et al., 1999). Similarly, Stickler and Thomas (1980) found that amongst 
the Gram negative isolates obtained from urinary tract infections, those belonging to the genera Proteus, 
Pseudomonas and Providencia were predominantly resistant to CHX at concentrations of more than 500 µg ml-1; 
whereas, most triclosan and para-chloro-meta-xylenol-tolerant strains, including P. aeruginosa and P. stutzeri, did 
not show increased resistance to other biocides like CHX, benzalkonium chloride (BAC) and phenol (Lear et al., 
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2006). On the other hand, screening of 472 clinical isolates and 693 stock cultures that included several species and 
also antibiotic resistant strains, found a low incidence of CHX resistance and no isolates exhibited high-level CHX 
resistance (Barry et al., 1999). Almost 98.5% of Gram negative non-fermentative rods isolated from dental unit 
water lines were killed by 0.12% CHX, which included 100% of all the D. acidovorans strains (Kotaka et al., 
2012). Very recently, an isolate identified as Aeromonas hydrophila was found to grow in 0.02% CHX in a natural 
water source in Kansas City, giving rise to a new healthcare concern. This strain was found to be resistant to 
various other antibiotics, including vancomycin, ampicillin, ciprofloxacin and tetracycline (Sekavec et al., 2013). 
There are mixed reports either agreeing (Lamfon et al., 2004; da Silva et al., 2014) or disagreeing (Bonez et al., 
2013) with the commonly-held paradigm that biofilm cells exhibit greater resistance to antimicrobials than their 
planktonic counterparts when CHX activity was specifically evaluated.  CHX was shown to be effective against 
biofilms of some microorganisms but not others; for example, Candida albicans biofilms were destroyed by MIC 
levels of CHX for planktonic cells, it was not the same situation in the case of P. aeruginosa and Acinetobacter 
baumannii biofilms. Thus, the composition of biofilms and penetration of CHX through the cell wall may influence 
the activity of CHX (Bonez et al., 2013).  
 
2.3.2. Effect of chlorhexidine on microbial biofilms 
Bacterial cells growing on surfaces as biofilms are in general protected from different kinds of 
environmental stressors, including antimicrobials. The majority of work conducted on CHX has thus far involved 
dental biofilms whereas relatively little research has examined pure culture biofilms. In general, pure culture 
studies have shown that CHX affects the viability of biofilm cells, the live dead ratio, biofilm structure and 
thickness.  Hope and Wilson (2004) observed the contraction of biofilms when exposed to 0.2% CHX, as well as 
time-dependent shifts in viability profiles through multispecies biofilms. In a study of the tongue biofilm 
microflora, Sreenivasan and Gittins (2004) reported that a 0.12% CHX mouth rinse resulted in a 90, 85, 90, 94 and 
81% decrease of anaerobic, Gram positive, Gram negative, H2S producing and proteolytic bacteria, respectively. 
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CHX treatment at a concentration of 0.2% resulted in greater reductions in viable counts and organic acid 
formation in polyacrylic grooves than in dentin grooves by Streptococcus mutans biofilms (Deng et al., 2004). 
Wilson et al. (1998) showed that biofilms grown in the presence of sucrose were more susceptible to CHX than 
those grown in the absence of sucrose, and that the dominant microflora of these two biofilm types varied. In 
addition, substantial numbers of bacteria remained viable even after exposure to 0.2% CHX for 60 min. Thus, 
CHX has potential as a selective agent, preferentially killing specific populations within a community as well as 
selecting for resistant community members. Using CLSM, Tremblay et al. (2014) showed that 0.525% CHX could 
kill biofilms formed by coagulase-negative staphylococci isolated from milking dairy cows as opposed to a lower 
level (0.001%) of CHX (Chiang et al., 2012) which killed only the inactive subpopulation of P. aeruginosa cells 
located in the deep layers of the biofilms leaving an active subpopulation located in the upper layer of the biofilm. 
The active subpopulation was able to tolerate CHX due to the use of some active genetic determinants in this case 
the mexCD-oprJ genes. CHX at MIC levels (1.5 µg ml-1) promoted biofilm detachment and inhibited detachment 
when concentrations were higher than the MIC and reduced detached-cell viability only at high concentrations (1.6 
times the MIC) in 48 h old Streptococcus mutans biofilms formed on polystyrene blocks (Liu et al., 2012). In this 
study, the effects of CHX on biofilm detachment differed depending on treatment time and concentration. The 
proportion of killing of bacteria in biofilms by CHX can also depend on the age of the biofilm (Shen et al., 2011). 
A TEM and SEM study revealed that 0.1% CHX did not induce ultra-structural alterations in an oral biofilm 
exposed to the biocide for 1 min although membrane damage and blebbing was observed in one third of the cells 
after a 5 min exposure at the same concentarion (Vitkov et al., 2005). Similarly, the prolonged exposure of S. 
mutans biofilms to sub-minimal bactericidal (4.5 µg ml-1) concentrations of CHX caused membrane rupture and 
loss of cytoplasmic contents while high concentrations (2000 µg ml-1) of the compound caused extensive 
precipitation of an unknown material on the slides (data not shown) (da Silva et al., 2014).  
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2.4. Antimicrobial resistance mechanisms in biofilms 
Antimicrobial resistance in biofilms is one of the most-studied topics in biofilm biology although there is 
no straightforward, or single, answer as to why biofilm microbial cells generally exhibit greater antimicrobial 
resistance compared to their planktonic counterparts. Indeed, the fundamental physical, chemical and biological 
mechanisms by which biofilm bacteria resist the killing effect of biocides and antibiotics remain incompletely 
understood. An examination of the literature indicates that antimicrobial biofilm resistance is a result of several 
factors that may act in combination and can vary from structural components of individual cells (e.g., outer 
membrane) to the biofilm structure itself (slow penetration through a thick biofilm) as well as the involvement of 
molecular level processes (Mah and Toole, 2001; Stewart and Costerton, 2001; Hoiby et al., 2010a; Mah, 2012). 
Russell (1995) summarised the mechanisms of bacterial resistance or tolerance to biocides and indicated that they 
could be either intrinsic, acquired, or both. Intrinsic resistance is defined as a natural chromosomally-controlled 
property of a bacterial cell that enables it to survive biocidal action and may vary between different strains of the 
same species. In terms of intrinsic resistance among vegetative bacteria, mycobacteria are probably the most 
resistant, followed by Gram negative bacteria, with the most sensitive being the Gram positive bacteria. Examples 
of intrinsic resistance traits include composition of outer cell layers, spore formation, phenotypic adaptation 
including biofilm formation and production of degradative enzymes (Morente et al., 2013). Acquired resistance 
results from genetic changes in a bacterial cell either through mutation or by acquisition of extra-chromosomal 
elements such as plasmids or transposons. Exposure to gradually increasing concentrations of biocide may also 
result in acquired resistance (Fitzgerald et al., 1992; Mangalappalli-Illathu and Korber, 2006). Similarly, 
permeability changes either through ultrastructural, compositional or hydrophobicity changes in the bacterial cell 
envelope may lead to acquired resistance, especially in Gram negative bacteria (Morente et al., 2013). Based on 
available data, Poole (2002) summarised that general tolerance to biocides, including CHX, typically does not 
develop following mutation of a particular target gene but rather involves broader cellular changes, such as up-
regulated efflux pump activity, alterations in cell wall permeability, and changes in fatty acid profiles. 
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In an earlier study, Suci et al. (1994) demonstrated that transport limitation could be an important factor in 
the antimicrobial resistance of biofilm bacteria; however, Mah et al. (2003) reported that biofilms themselves may 
not act as a diffusion barrier to antibiotics but the bacterial cells within these biofilms may have some distinct 
resistance mechanisms to combat the action of antimicrobials. To prove this, they showed that the periplasmic 
glucans produced by ndvB contributed to antibiotic resistance in biofilms by sequestering the antibiotics and 
preventing them from reaching their cellular targets. Zhang et al. (2013) suggested that when two or more genes 
that are not functionally-related are responsible for antibiotic resistance, multiple biochemical pathways need to be 
considered as contributors for this trait. Only the major antimicrobial resistance mechanisms will be discussed in 
detail in this section, in particular, those that are deemed relevant to this thesis, and where available, those that are 
applicable to CHX. The mechanisms associated with biofilm resistance to CHX have received varying degrees of 
attention and the literature consists of largely phenomenological descriptions of its occurrence rather than in-depth 
studies of the actual mechanisms involved. 
Some bacterial genera (e.g., Proteus, Providencia) may either be intrinsically-resistant to CHX or have 
inducible mechanisms of resistance due to phenotypic and genetic changes. Protection against antimicrobial agents 
could also be mediated through the existence of sub-populations of resistant cell phenotypes in the biofilm known 
as 'persisters' (Stoodley et al., 2004; Keren et al., 2004). Russell and Day (1993) indicated in their review that the 
genetic basis of CHX resistance may be due to transfer by recombinant plasmids (as seen in S. aureus), by genetic 
transformation (Streptococcus sanguis), or through chromosomally mediated mechanisms. The authors added that 
one of the reasons for high levels of CHX resistance may be associated with the barrier properties presented by the 
outer membrane of organisms, as well as the existence of microorganisms in the form of biofilms. In general, a 
single target site or point-mutations, are rare in the case of resistance to biocides due to their cell-wide, non-
specific modes of action (Russell, 2003).  
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2.5. Chlorhexidine resistance in biofilms 
It is commonly reported that bacterial biofilms may be up to 1,000 times more resistant than their 
planktonic counterparts (Nickel et al., 1985; Tremblay et al., 2014). Several mechanisms have been proposed to 
explain the general of biofilms to biocidal agents, the most common of which are the barrier properties of the 
‘slime’ matrix or reduction in access via reaction-diffusion kinetic limitations imposed by biofilm components 
(Chapman, 2003). A study by Fitzgerald et al. (1992) showed that the uptake of 14C-CHX by strains of P. 
aeruginosa and E. coli was very rapid (within 20 s). Despite the rapid uptake, the lethal action of CHX was 
comparatively slow. Their study further determined that penetration failure is the most common resistance 
mechanism when dealing with thick biofilms and highly- reactive antimicrobials such as CHX. In contrast, studies 
using ciprofloxacin and tobramycin in P. aeruginosa biofilms indicated that limited antibiotic diffusion was not the 
primary protective mechanism for resistance in these biofilms. Rather, protection was mediated via oxygen 
limitation and low metabolic activity in the interior of the biofilm (Walters et al., 2003). Similar conclusions were 
made in another study (Anderl et al., 2000) wherein antibiotic inactivation or slow diffusion were not the 
mechanisms of resistance to ampicillin and ciprofloxacin in Klebsiella pneumoniae biofilms. The slow growth of 
microorganisms within biofilms reduces their susceptibility to biocides by a number of factors that include nutrient 
depletion within the biofilm, chemical interaction between the biocide and biofilm cells, and production of 
neutralizing enzymes and chemicals (Gilbert and Moore, 2005).  
 
2.5.1. Chlorhexidine resistance by microbial/enzymatic degradation  
Enzymatic resistance can be achieved either by destroying or by modifying the antimicrobial compound. 
The chemical strategies of antibiotic inactivation include hydrolysis, group transfer, and redox mechanisms 
(Wright, 2005). Examples include the enzyme β-lactamase produced by P. aeruginosa which inactivates many β-
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lactam antibiotics by β-lactam ring cleavage (Bagge et al., 2004). Acetylating or adenylating enzymes produced by 
some Gram negative bacilli cause increased resistance to gentamicin (Dornbusch and Hallander, 1980). CHX 
degradation by activated sludge communities has also been reported (Sayama, 1981; Sakagami et al., 1983). 
Tanaka et al. (2005) reported that a Pseudomonas sp. strain degraded CHX to a number of transient intermediate 
compounds which were identified using HPLC methods. Results indicated that two pathways were involved in this 
degradation process. Interestingly, the MIC values for the degradation end products like CHDI-B (C25H34Cl2N10O2) 
and CHDI-C (C24H32N10Cl2) were found to be 5 to 10 times higher than for CHX itself.  Other CHX end products, 
such as p-chlorphenylurea and p-chloraniline, had no antimicrobial activity (Tanaka et al., 2005). CHX degradation 
by clinical isolates of P. aeruginosa, P. cepacia, Alcaligenes faecalis, Alcaligenes xylosoxidans, Serratia 
marcescens and Pseudomonas sp. strain A-3 (as a control CHX-degrading organism) have also been investigated 
(Uyeda et al., 1996). Among these organisms, only S. marcescens showed similar degradation, via a modified 
pathway, as the control organism. A Pseudomonas sp. and a Flavobacterium sp. showed different patterns of CHX 
degradation, wherein the former yielded transient intermediates and the latter did not (Kido et al., 1988). Strains of 
P. aeruginosa converted CHX to p-chloroaniline, p-chlorophenol, p-chloroacetoanilide, phenol, aniline, 
pyrocatechol and pyrogallol (Sakagami et al., 1986). Hence, degradation can be considered as one of the potential 
mechanisms for resistance to CHX by some bacteria. 
 
2.5.2. Role of the outer membrane in chlorhexidine resistance 
 Several authors have focused on the role of the outer membrane as a physical barrier to the effects of 
antibiotics, disinfectants and detergents, especially in Gram negative bacteria (Hancock, 1997; Dykes et al., 2003; 
Sampathkumar et al., 2004; Ruiz et al., 2006). The OM separates the periplasm of bacterial cells from the external 
environment, and owing to its physical properties, acts as a selective barrier, preventing the entry of many toxic 
molecules into the interior of the cell, a property that is considered crucial for survival in many environments. 
Similar speculation suggesting that the OM plays a key role has been made regarding the membrane-active agent 
 21 
CHX (Richards and Cavill, 1979; Russell and Path, 1986; Kuyyakanond and Quesnel, 1992; Tattawasart et al., 
2000a, b; Maillard, 2002; Castillo et al., 2006). Cationic antimicrobials such as CHX bind to the negatively-
charged lipopolysaccharide (LPS) of the outer membrane and subsequent entry into the cells depends on the 
transmembrane electrical potential (Damper and Epstein, 1981; Bryan and Kwan, 1983). Any change in the LPS 
can increase or decrease the binding affinity of the LPS for polycations, thus making the cells more or less 
susceptible to these antimicrobials (Rivera et al., 1988).  Divalent cations like calcium and magnesium maintain 
the integrity of the OM, and thus the presence of a chelator-like EDTA can disrupt the OM, increasing the 
susceptibility to hydrophobic compounds (Ayres et al., 1998; Russell, 2003; Ruiz et al., 2006) and antibiotics 
(Hancock, 1997). Overall changes in the protein content (Gandhi et al., 1993) and fatty acid composition (Guérin-
Méchin, 1999; Méchin et al., 1999) have also been shown to influence the susceptibility of Gram negative bacteria 
to antimicrobial agents. Adaptation of S. marcescens to 0.006% CHX was consistent with alterations in the outer 
membrane proteins (Gandhi et al., 1993). Pseudomonas aeruginosa cells adapted to a quaternary ammonium 
compound (QAC) showed variations in membrane fatty acid composition with significant involvement of five fatty 
acids, namely lauric acid (C12 : 0), β-hydroxycapric acid (C10 : 0 β-OH), α- and β-hydroxylauric acids (C12 : 0 α- 
and β-OH), and palmitoleic acid (C16 : 1 cis 9) (Guérin-Méchin et al., 1999). The total lipid content of C. albicans 
grown in the presence of a sub-inhibitory concentration of CHX declined while the total sterol content was 
increased compared to control cells. CHX-exposed yeasts had a higher level of phosphatidylethanolamine, 
phosphatidylcholine and monogalactosyldiacylglycerol and lower proportions of phosphatidylinositol, 
phosphatidylserine, phosphatidic acid, cardiolipin and higher proportions of palmitic acid (16: 0) and stearic acid 
(18: 0), but lower proportions of palmitoleic acid (16: 1) and oleic acid (18: 1). CHX also decreased the 
unsaturated-to-saturated fatty acid ratio, while the C16/C18 ratios increased compared to control cells (Abu-Elteen 
and Whittaker, 1997). 
The presence of porins and negatively charged LPS in combination with an active efflux system is probably 
responsible for the high resistance of the Gram negative OM to externally added detergents and dyes (Hancock, 
1997). However, Gilbert and Moore (2005) reported that resistance to CHX was based on action at the OM and 
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that multi-drug efflux pumps did not play a role, presumably because the bisbiguanide is not soluble within the 
membrane core.  Russell (2003) also indicated that resistance to CHX by Gram negative organisms like P. 
aeruginosa is due to reduced uptake of the biocide owing to an impermeable cell membrane. Differences in the 
OM and release of cell contents were observed in CHX-treated P. aeruginosa and P. cepacia cells at CHX 
concentrations of 10.0 and 3.0 µg ml-1, respectively (Richards and Cavill, 1981). A previous study by the same 
group (Richards and Cavill, 1979) showed that low levels of CHX (2.0-3.0 µg ml-1) acted primarily on the 
cytoplasmic membrane and on the cytoplasmic membrane plus layers external to it at concentrations greater than 
3.0 µg ml-1. The oprD, E, L and F genes that encode OM proteins for maintaining the integrity of the OM and 
control of OM permeability in P. aeruginosa were found to be down-regulated after 60 min of CHX exposure, 
indicating that CHX treatment affected OM permeability (Nde et al., 2009).  The presence of an anion-selective 
porin from Comamonas acidovorans, Omp32, has been reported and may have biological implications in terms of 
strong selectivity and specificity for extra-cellular molecules (Zeth et al., 2000).  
Transmission electron microscopy (TEM), scanning electron microscopy (SEM) and energy dispersive X-
ray analysis (EDAX) have been used to examine the effects of chlorhexidine diacetate (CHA) on CHA-sensitive 
and CHA-resistant isolates of P. stutzeri. CHA caused structural damage and extensive lysis to CHA-sensitive 
cells; whereas, no such effect was seen on CHA-resistant cells. The results of X-ray mapping confirmed the 
difference in CHA uptake between these two groups of isolates. The concentration and distribution of magnesium 
and calcium (both involved in the structural organization of the outer membrane), phosphorous (structural element) 
and chlorine (marker for CHA) were studied and the results led the authors to conclude that the major mechanism 
of CHA resistance in P. stutzeri may be linked to changes in the binding sites available in the outer membrane. 
They speculated that deletion or depression of a porin protein resulted in the decrease in cell permeability 
(Tattawasart et al., 2000a,b).  
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2.5.3. Role of efflux pumps in chlorhexidine resistance 
The role of energy-driven drug efflux systems as a mechanism of antibiotic resistance has been extensively 
studied and reviewed (Lomovskaya et al., 2001; Poole, 2001; Levy, 2002). Efflux pumps are transporter proteins 
that extrude toxic substances from within the cells into the external environment by being specific to one substrate 
or a range of structurally-similar compounds, in the latter case leading to multidrug resistance. Efflux pumps are 
found in both Gram positive and Gram negative bacteria. It has been estimated that approximately 5–10% of all 
bacterial genes are involved in trans-membrane transport and a large proportion of these genes encode efflux 
pumps (Webber and Piddock, 2003). Bacterial efflux pumps can be broadly divided into five classes: the small 
multidrug resistance (SMR) family, the major facilitator superfamily (MFS), the ATP-binding cassette (ABC) 
family, the resistance-nodulation-division (RND) family and the multidrug and toxic compound extrusion (MATE) 
family (Webber and Piddock, 2003).   
Efflux proteins in P. aeruginosa have been widely studied and shown to be associated with resistance to 
antibiotics and biocides, including CHX. Sequencing of the P. aeruginosa genome has revealed at least 12 efflux 
pumps, of which the MexAB-OprM pump is the most extensively characterized and most commonly-expressed in 
wild type strains. This efflux pump has been found to act on a range of antibiotics and dyes (Srikumar et al., 1998), 
including cationic agents like aminoglycosides (Li et al., 2003). Chromosomally-located or acquired by bacteria, 
efflux pumps can either be activated by environmental signals or by a mutation in a regulatory gene. One such 
pump, the AcrAB pump, extrudes biocides such as triclosan, CHX and quaternary ammonium compounds, as well 
as multiple antibiotics. The multidrug efflux operon mexCD-oprJ was found to be induced by CHX in P. 
aeruginosa (Morita et al., 2003; Fraud et al., 2008; Nde et al., 2009) and was found to be dependent on the stress 
response sigma factor, AlgU (Fraud et al., 2008), which is homologous to RpoE in E. coli. CepA, a cation efflux 
pump, is associated with CHX resistance in K. pneumoniae and possibly in other Gram negative bacteria (Fang et 
al., 2002; Kishk et al., 2014). The RND efflux system may be primarily responsible for CHX resistance in Gram 
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negative bacteria such as P. aeruginosa (Nde et al., 2009) and Burkholderia cenocepacia (Coenye et al., 2011); 
whereas, the AdeABC efflux system has been reported in clinical A. baumannii isolates (Rajamohan et al., 2010; 
Hassana et al., 2013). Association of the qacA/B efflux gene and CHX tolerance or has been demonstrated in 
several studies in S. aureus (Smith et al., 2008; Wang et al., 2008). 
Several studies have concluded that although the OM of P. aeruginosa has very low non-specific 
permeability, this alone is not sufficient to explain their high resistance to a wide variety of toxic molecules and 
that interplay between OM and multidrug efflux pumps would be required. Efflux pumps work synergistically with 
the outer membrane. The OM itself does not provide resistance to antibiotics as it only has decreased permeability. 
Studies on the interplay between efflux pumps and the OM in cases of multiple antibiotic resistance have been 
conducted in P. aeruginosa; however, these studies have been restricted to planktonic cell cultures.  No such study 
has been reported in biofilms. Inactivation of MexA-MexB-OprM multidrug efflux pump and increasing the OM 
permeability by use of permeabilizers such as EDTA and NaHMP have been shown to enhance the antibiotic 
susceptibility in P. aeruginosa (Li et al., 2000). Similarly, Germ et al. (1999) demonstrated the interplay between 
MexAB-OprM and the OM permeability barrier in lowering the intracellular concentration of fluorescent dyes in 
P. aeruginosa. In this case, they used EDTA (0.1 mM) and polymyxin B (2.5 µg ml-1) to enhance the permeability 
of the OM.    
 
2.5.4. Role of persister cells in CHX resistance 
In 1944, Joseph Bigger discovered a sub-population of cells within a Staphylococcus culture that survived 
repeated exposures to penicillin and differentiated them from resistant mutants as persisters. Recently, Zhang 
(2014) summarized the drawbacks of previous definitions of persister cells, and proposed a Yin-Yang model to 
better describe this phenomenon. His new definition is as follows; “persisters refer to genetically-drug-susceptible 
quiescent (non-growing or slow growing) organisms that survive exposure to a given antibiotic or drug and have 
the capacity to revive (regrow or resuscitate and grow) under highly-specific conditions”. 
 25 
The persister cell theory has gained serious attention in recent times as it is now believed that these dormant 
variants are most likely responsible for the recalcitrance of chronic infectious diseases to antimicrobial treatments 
and can promote multidrug tolerance. It is quite challenging to use the existing antibiotics effectively against 
dormant persister organisms. The principal role of persisters in biofilm antimicrobial tolerance and chronic 
infections have been reported and reviewed extensively (Harrison et al., 2005; Lewis et al., 2005; LaFleur et al., 
2006; Mulcahy et al., 2010). LaFleur et al. (2006) demonstrated the existence of persisters in C. albicans biofilms 
treated with CHX and that they were not mutants but phenotypic variants of the wild type. They also concluded 
that effluxers do not contribute to persister survival and CHX resistance in C. albicans biofilms. Furthermore, 
quorum sensing did not seem to play a role in persister formation in E. coli and persister numbers increased in the 
mid-exponential phase, reaching a maximum of ∼1% persisters in the stationary phase (Lewis, 2007). 
It is now known that several genes and pathways are involved in persister formation and survival and this is 
discussed in detail later in the proteomic section of this chapter. Generally, persister genes belong to the SOS stress 
response systems, hipA being the first bonafide persister gene (Keren et al., 2004). Some of the multidrug tolerant 
loci found in E. coli persisters are hipBA toxin/antitoxin loci (Keren et al., 2004), sn-glycerol-3-phosphate 
dehydrogenase GlpD and plsB, and sn-glycerol-3-phosphate acyltransferase (Spoering et al., 2006). 
 
2.6. Microscopic analysis of microbial biofilms  
Microscopic examination of biofilms began in the days of Antonie van Leeuwenhoek (1684) and has 
naturally undergone considerable advancements since then. Developments in microscopy have enabled researchers 
to develop a better understanding of biofilm structure and function, as well as to study their interactions with 
various antimicrobials (Vitkov et al., 2005; Mangalappalli-Illathu and Korber, 2006; Dynes et al., 2009; Neu et al., 
2010; Shen et al., 2011; Tremblay et al., 2014). Microscope-based techniques such as confocal laser scanning 
microscopy (CLSM), transmission electron microscopy (TEM) and scanning transmission X-ray microscopy 
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(STXM) have been used singly, or in combination, to examine complex microbial communities as well as to map 
the extent, nature and distribution of macromolecules in a biofilm (Lawrence et al., 2003; Dynes et al., 2009). Each 
technique has its own advantages and disadvantages and can be selected based on the application and objectives to 
be achieved (Neu et al., 2010; Pantanella et al., 2013).  
Confocal laser scanning microscopy is a non-invasive, non-destructive method that may be used to monitor 
biofilms in situ. It is a powerful technique that not only allows researchers to take images with microscopic 
resolution, but also reveals the system’s three-dimensional structure. Cell viability, cell morphology, biofilm 
architecture and matrix composition can be studied in living, fully-hydrated systems using CLSM (Korber et al., 
1994; Lawrence et al., 2003; Shen et al., 2011). Multi-wavelength/channel visualization of the biofilms is one of 
the greatest advantages of using this technique. Microbial communities can be identified using CLSM and rRNA-
targeted oligonucleotide probes using the fluorescence in situ hybridization technique and structure-function 
relationships can be also be studied using fluorescent reporter genes such as green fluorescent protein (GFP) (Neu 
et al., 2010). Many authors have used CLSM to visualize the three-dimensional structure of biofilms and compared 
this approach to other microscopic techniques such as electron microscopy. Manz et al. (1999) employed CLSM to 
study the three-dimensional structure and dynamics of bacterial communities in river biofilms generated using a 
rotating annular reactor system. Eaglesham et al. (2003) used CLSM to observe the channels, pores, and other 
structural features of a biofilm matrix grown in lake water. Similarly, many other research groups have employed 
CLSM for biofilm studies (Battin et al., 2003; Teitzel and Parsek, 2003; Hope and Wilson, 2004; Lawrence et al., 
2005; Shen et al., 2011) in conjunction with vital staining or fluorescent probing techniques. Fluorescent dyes such 
as SYTO9 and propidium iodide can be employed in combination with CLSM to evaluate the potential for 
antimicrobial agents to influence membrane integrity and permeability (Dynes et al., 2009; Tremblay et al., 2014). 
Hope and Wilson (2004) concluded in their study that fluorescent indicators can readily be used to investigate the 
penetration and antimicrobial effects of membrane active biocides like CHX on biofilms. Because it is known that 
CHX damages the bacterial membranes, its bactericidal action can be measured in real time using probes like the 
BacLight LIVE/DEAD nucleic acid stain. This stain, which is sensitive to the condition of the cell’s cytoplasmic 
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membrane, has been used by a number of other research groups for viability studies in biofilms. Decker et al. 
(2003) used these stains for susceptibility studies of Streptococci sanguinis cells to CHX. The morphology and 
viability of Staphylococci biofilms exposed to CHX was examined using CLSM and staining techniques (Tremblay 
et al., 2014).  The observations included reduction in the amount of bacteria and presence of a fairly large amount 
of permeabilised cells, as indicated by red cells after CHX treatment. Vitality distribution in CHX-treated biofilms 
is dependent on a number of factors, such as the substrate on which the biofilms have been formed, treatment of the 
biofilms before imaging (intact hydrated versus dried and fixed biofilms) and unclear distinction between red and 
green (“dead” and “living”, respectively) cells due to the presence of an intermediate orange color (Zaura-Arite et 
al., 2001). Measurements such as biofilm thickness, percentage of live cells, and distribution of live cells at various 
depths have been obtained using CLSM to study the bactericidal effect of CHX treatment on undisturbed plaque 
biofilms grown on bovine dentin discs (Zaura-Arite et al., 2001). Similarly, Shen et al. (2011) used CLSM and 
Live/Dead vitality stain to study antimicrobial efficacy of CHX against bacteria at different stages of development 
and concluded that CHX resistance (in terms of proportion of dead cells) was dependant on the age of the biofilm. 
Chiang et al. (2012) used CLSM in combination with GFP markers to study the molecular determinants of CHX 
resistance in P. aeruginosa biofilms. Using propidium iodide staining they showed that CHX at 0.001% killed the 
inactive subpopulation located deep in P. aeruginosa biofilms; whereas, the active subpopulation located in the 
upper layer of P. aeruginosa biofilms survived the biocide treatment. In addition, using this technique they also 
demonstrated that development of CHX-tolerance was dependent on the presence of mexCD-oprJ genes, but did 
not depend on the pmr, mexAB-oprM, mexPQ-opmE, or muxABC-opmB genes.  
The distribution and concentration of CHX in combination with biomacromolecules (e.g., proteins, lipids, 
polysaccharides) can further be investigated using STXM at a spatial resolution of <30 nm in hydrated biofilm 
systems (Dynes et al., 2006a, 2009).  STXM was first developed by Kirz and Rarback (1985). Based on the 
differences in the elemental composition and bonding structure of a particular chemical species, the STXM 
approach uses the near edge X-ray absorption spectrum (NEXAFS) (Stohr, 1992) so that the chemical state and the 
morphology of the sample can be directly correlated (Bluhm et al., 2006). Both soft and hard X-rays can be used 
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for this purpose since most elements have an absorption edge in both energy ranges; however, soft X-rays are 
preferentially-used over hard X-rays to collect C, N and O information for quantitative mapping of organic 
biomolecules in biofilms. STXM at the C 1s edge has been exploited in several studies for mapping the major 
biomacromolecules in a biofilm (Lawrence et al., 2003, 2012; Dynes et al., 2009; Liu et al., 2013; Rema et al., 
2014).  Sequences of images are recorded over a span of photon energies at core excitation edges by scanning the 
sample through the focal point of a zone plate X-ray lens and measuring the intensity of transmitted X-rays. This 
data is converted to quantitative maps of these compounds using suitable quantitative reference spectra. The 
sequence of images collected at a range of different energies is referred to as an image “stack”. Using this 
principle, synchrotron x-ray microscopy can be used to obtain a detailed mapping of biofilm structure and to 
understand the biochemical basis for biofilm formation. STXM is ideally suited to investigate small particles, 
membranes and whole bacteria immersed in aqueous solution with minimal sample preparation since soft X-rays 
can penetrate water; however, the sample thickness can be a limiting factor (soft x-rays penetrate poorly through 
thick biofilms). Lawrence et al. (2003) carried out correlative mapping studies of structure, composition and 
distribution of macromolecular components in a river biofilm system using TEM, CLSM, and soft X-ray scanning 
transmission microscopy (STXM). Such correlative approaches with synchrotron-based and other 
microspectroscopic and imaging techniques will allow a better understanding of both the fate and effects of 
environmental contaminants and chemicals when interacting with microbial biofilms. It is believed that STXM 
data may be better than TEM owing to its higher energy resolution and reduced photon damage of the sample 
(Wang et al., 2009). However, spectral fitting of organic contaminants for proper distinction against organic 
biomolecules in a microbial biofilm can be challenging and may warrant a different approach for such studies. Obst 
et al. (2009) used STXM to study calcium precipitation by cyanobacteria and the role of EPS in this process. They 
were successful in investigating the earlier stages of cyanobacterial biomineralisation which was not possible by 
other techniques such as Raman spectroscopy, CLSM or TEM because of the small spatial scale involved and also 
due to the limited speciation capability and production of artifacts in the sample leading to underestimation of the 
biological components, particularly the EPS. Dynes et al. (2006a) employed STXM to investigate the speciation 
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and distribution of metals in a river microbial biofilm. An additional study (Dynes et al. 2006b) demonstrated the 
mapping of CHX in microbial biofilms and demonstrated its association with cellular lipids. Three-dimensional 
imaging of samples using STXM was also achieved with ∼50 nm spatial resolution (Johansson et al., 2007). 
Therefore, this imaging approach has considerable potential in studies of fate and effects of CHX in microbial 
biofilms. 
Similar to STXM, infra-red (IR) spectroscopy is a non-destructive technique that requires minimal sample 
preparation to study biological materials wherein the IR portion of the spectrum is used to study the vibrational and 
rotational motions of atoms in molecules. Vibrational spectroscopic methods are based on the absorption (Fourier 
transformed infrared spectroscopy-FTIR) or scattering (Raman microscopy) of light directed onto a sample. The IR 
spectrum is obtained by determining the fraction of incident radiation that is absorbed by the sample at a particular 
energy and each peak in the spectrum corresponds to the vibration of a part of the sample molecule. In FTIR 
microspectroscopy, every pixel in an image corresponds to a complete IR spectrum that in turn correlates to the 
chemical composition of the analysed spot. Common biomolecules, such as nucleic acids, carbohydrates, proteins 
and lipids, have characteristic vibrational modes that are used in microbial and ecological studies. Thus, vibrational 
signatures of chemical bonds in biomolecules within a biofilm with a spatial resolution of <10 µm can be obtained 
using synchrotron radiation-based Fourier transformed infrared spectroscopy (SR-FTIR). Most of the relevant 
biological information can be obtained from the mid-infrared region (4000-800 cm-1) (Suci et al., 1998).  Different 
covalent bonds have specific IR absorption peaks that change based on structural/bonding modifications and it is 
this principle that is taken advantage of while investigating the environmental influence on biological samples such 
as biofilms. SR-FTIR microscopy offers good signal to noise ratio and wave number precision (Griffiths, 1983) 
and can be used to track biogeochemical changes within a biological sample with high sensitivity and micrometer 
spatial resolution in real time (Holman et al., 2009b) with a power below the threshold for cytotoxic effects 
(Holman et al., 2002). Infrared absorption spectra of organic molecules provide unique “fingerprints” that can be 
applied for identification purposes of microbes with great reliability (Suci et al., 1998).  Strong amide I (between 
1690 and 1650 cm-1) and amide II (1550 cm-1) versus an enlarged O-H and carbonyl peak at 1740 cm-1 helped to 
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differentiate between two groups of bacteria, E. coli from Bacillus subtilis cells, in an extensive study reported by 
Nichols et al. (1985). In this study, the authors were also able to recognise the differences in microbial community 
structure by subtracting the spectra obtained for these two groups of bacteria.  Differences in the band pattern were 
also seen in bacterial polymers such as gum arabic and poly-β-hydroxybutyrate (PHB). Bacterial biofilm changes 
that occurred during: i) adaptation to their surrounding environments, ii) transportation, adsorption and interaction 
kinetics of antimicrobial agents within the biofilms (Suci et al., 1994; Suci et al., 2001; Holman et al., 2009a); 
Rema et al., 2014) and iii) biofilm developmental stages (Quiles et al., 2010) have also been monitored using SR-
FTIR. Reuben et al. (2014) combined CLSM with SR-FTIR imaging to better understand the spatial chemical 
composition of multispecies biofilms grown from natural storm waters in flow cells especially with respect to high 
density and void regions of the biofilm. 
 
 
2.7. Gene expression during the biofilm mode of growth 
Genetic and molecular studies of bacterial communities have helped us to get a better understanding of the 
various stages of bacterial attachment and biofilm development, mechanisms of antimicrobial resistance and in 
formulating methods to control biofilm infections. The first report of gene expression owing to a biofilm phenotype 
was made using lacZ reporter-gene fusions (Davies et al., 1993). A phenotypic shift in behavior in conjunction 
with differential regulation of a large array of genes is associated with cells when they switch from planktonic to 
biofilm mode of growth (Whiteley et al., 2001; Prigent-Combaret et al., 1999).  In spite of the distinguishable 
characteristics of these two modes of growth, only 1% of genes of P. aeruginosa showed differential expression 
between them, whereby 0.5% of genes were expressed and 0.5% were repressed in the sessile mode (Whiteley, et 
al., 2001). However, based on a review of several studies Sauer (2003) reported that the up- and down-regulation 
of genes could vary between 1% and 38% of the total genome and may be just a transient snapshot of gene 
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expression which may not necessarily be correlated to the phenotype. It has also been demonstrated that various 
proteins are involved in different stages of biofilm development. Surface-associated proteins, such as SpaP and 
Fap1 (Bowen et al., 1991; Froeliger and Taylor 2001) and glucan binding proteins (Sato et al., 1997) such as 
GbpA, GbpB, and GbpC play an important role in the initiation and formation of biofilms by oral streptococci. 
Bacterial cell surface proteins or extracytoplasmic proteins such as ClpP play a role in the initial attachment of 
bacteria to abiotic surfaces and biofilm formation (O’Toole and Kotler, 1998).  Structural proteins involved in 
adhesion and autoaggregation, such as OmpC, OmpF, OmpT, lpxC (encoding a protein associated with lipid A 
biosynthesis), and slp (encoding an outer-membrane lipoprotein) were over-expressed in the biofilm growth 
compared with planktonic growth (Schembri et al., 2003), although no genes regulated in response to quorum 
sensing were found. A global proteome analysis of P. putida cells after a 6 h attachment period to a silicone surface 
was carried out using 2-D protein gel electrophoresis and cDNA subtractive hybridization techniques (Sauer and 
Camper, 2001). Their study revealed 45 differences in the protein profiles of planktonic and sessile cells, wherein 
those involved in amino acid metabolism, OM lipoprotein, putative ABC transporter (PotF) and proteins involved 
in flagellar synthesis were down-regulated, whereas proteins for synthesis of type IV pili and lipopolysaccharides 
and the ABC transporter (PotB) were up-regulated in the attachment mode. Through a DNA microarray study, 
Whiteley et al. (2001) demonstrated that appendages like pili and flagella were not required during the maturation 
and maintenance stages of biofilm development; whereas, the TolA membrane protein and OmlA membrane 
lipoprotein were induced in the biofilm cells. RpoS, the σS subunit of RNA polymerase, governs the expression of 
many genes during the stationary phase, and deletion of rpoS rendered E. coli incapable of establishing sessile 
communities (Schembri et al., 2003). However, an opposite effect was seen in P. aeruginosa wherein the rpoS 
gene was repressed in biofilms and rpoS-deficient mutants formed thicker biofilms than the wild type cells and 
were more resistant to antimicrobial treatment (Whiteley et al., 2001). 
Using in vivo expression technology, five new essential genes were identified for P. aeruginosa biofilms 
(Finelli et al., 2003) which had not been detected in previous DNA microarray analyses. Using GeneChip 
Expression analysis, several SOS stress response genes were found to be expressed in E.coli persister cells (recA, 
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sulA, uvrBA, and umuDC); the phage-shock (psp) operon genes; and several heat and cold shock genes (cspH, 
htrA, ibpAB, htpX, and clpB) and those belonging to TA modules dinJ/yafQ, yefM, relBE, and mazEF (Keren et al., 
2004). Hefford et al. (2005) used a 2-dimensional polyacrylamide gel electrophoresis technique to study the 
proteomes of biofilm- and planktonically-grown Listeria monocytogenes and found that the proteins involved in 
stress response, envelope and protein synthesis, biosynthesis, energy generation, and regulatory functions were 
highly-expressed in biofilm-grown cells. Very recently, Mosier et al. (2014) used tandem mass tag (TMT)-based 
proteomics to investigate the proteomic response of individual organisms within a biofilm community to elevated 
temperatures, thus paving the way for studies of gene expression in mixed culture and environmental samples. 
 
2.8. Gene expression during antimicrobial treatment of microbial biofilms 
A review of published literature shows that several genes can be expressed upon antimicrobial treatment 
and will depend on several factors such as the type of antimicrobial and microorganism, treatment conditions, 
concentration of the antimicrobial and exposure time. Exposure of P. aeruginosa biofilms to high concentrations of 
tobramycin resulted in expression of 20 genes that may be responsible for biofilm resistance to this antibiotic 
(Whiteley et al., 2001).  DNA microarray technology was used in this study to gain possible insights into bacterial 
antibiotic resistance mechanisms.  Among them, the role of tolA, rpoS and cytochrome c oxidase in antibiotic 
resistance was discussed in detail. Other proteins induced were hypothetical proteins of unknown function, efflux 
proteins and stress response proteins (dnaK and groES). Activation of genes encoding efflux pumps was suggested 
to be responsible for P. aeruginosa biofilm resistance to antibiotics (Greenberg, 2000; Whiteley et al., 2001). 
Zhang et al. (2013) characterised three specific antibiotic resistance loci in P. aeruginosa biofilms. They included 
ndvB that encodes a glucosyltransferase, important for the synthesis of cyclic-β 1, 3 glucans, an operon that 
encodes an efflux pump and tssC1 through an unknown mechanism.  
Proteomic studies on Delftia biofilms and on biofilms treated with CHX are very limited.  The first study 
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on global transcriptomic response of P. aeruginosa treated with CHX was published in 2009 by Nde and co-
researchers (Nde et al., 2009). They studied the response of P. aeruginosa to treatment with 0.008 mM CHX 
diacetate for 10 and 60 min using P. aeruginosa GeneChip arrays and found that out of a total of 5900 genes, 250 
genes were statistically-significantly up-regulated (≥2-fold) or down-regulated (≤2-fold). A few studies have 
indicated that the most prominently down-regulated genes under CHX stress were those encoding heat shock 
proteins (Nde et al., 2009; Hassana et al., 2013). Apart from these, the other genes that were down-regulated in the 
study of Nde et al. (2009) at both exposure times (10 and 60 min) to CHX were membrane transport, oxidative 
phosphorylation and electron transport genes. The mexC and mexD genes of the MexCD-OprJ multidrug efflux 
pump were significantly up-regulated after both treatment times. On the other hand, only 22 and 35 genes were up- 
and down-regulated by more than two-fold, respectively, when Acinetobacter baumannii cells were exposed to 4 
mg L-1 CHX in a whole genome microarray study (Hassana et al., 2013). In yet another microarray study (Coenye 
et al., 2011), of the 7,153 protein-coding B. cenocepacia J2315 genes, 469 (6.56%) were significantly over-
expressed by more than two-fold in CHX-treated sessile cells, while 257 protein-coding genes (3.59%) were 
significantly down-regulated. The majority of over-expressed genes encoded periplasmic and lipoproteins and were 
required for the structure and function of the inner membrane, were involved in transport or binding, had 
regulatory functions, or were involved in chemotaxis and motility. The majority of down-regulated genes in sessile 
CHX-treated B. cenocepacia J2315 cells were involved in transport or binding or had a regulatory function similar 
to the findings of Nde et al. (2009). In a comparative study of the action of CHX on membrane proteins of Gram 
positive (Bacillus subtilis) and Gram negative bacteria (E. coli), Cheung et al. (2012) found that five proteins 
related to purine nucleoside interconversion and metabolism were preferentially expressed in the cell wall of E. 
coli, while three proteins related to stress response and four others in amino acid biosynthesis were up-regulated in 
the cell wall of B. subtilis. In a very recent comparative analysis of CHX-sensitive and CHX-tolerant strains of 
Salmonella typhimurium, Condell et al. (2014) reported the involvement of a CHX defense network in both cases. 
The defense network involved multiple cell targets such as those associated with the synthesis and modification of 
the cell wall, the SOS response, virulence, and an anoxic pathway metabolism with no involvement of efflux 
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systems. In addition to extensive modifications of these cellular processes, up-regulation of the flagellar apparatus 
and altered phosphate metabolism was seen in CHX-tolerant cells. In the same study, using the differential in gel 
electrophoresis (DIGE) technique, the authors reported that after a sub-lethal exposure to CHX, a total of 247 
proteins were significantly differentially-expressed (>2-fold-change, p < 0.05); 81 of these genes were up-regulated 
whilst 166 were down-regulated in the CHX-sensitive strain. Some of the proteins associated with cellular 
permeability that were expressed in CHX-treated Salmonella wild type cells included those involved in the 
biosynthesis and cross-linking of the peptidoglycan subunits (murG, murD), thus affecting the efficacy of CHX 
action and/or transport. The O-antigens that provide anionic binding sites were down-regulated, thus altering CHX 
binding to the cells. Up-regulation of the DNA repair system was also observed in keeping with other studies (Nde 
et al., 2009) to mitigate the DNA cross-linking effects of CHX with a decrease in protein synthesis. 
 
2.9. The Tol System 
The extracellular toxins produced by E. coli and Pseudomonas species (i.e., colicins, pyocins) must cross 
the membrane barrier of the target cells to exert their lethal action. In order to achieve this, they must first 
recognize a specific receptor in the bacterial OM and then translocate through the cell envelope. Colicins, and 
similarly, single-stranded DNA of some filamentous bacteriophages use two different translocation systems to 
cross the cell envelope; namely, the Ton and Tol systems. Dennis et al. (1996) reported the first Pseudomonas tol 
mutant that was tolerant to pyocin; however, most of the studies in this area have taken place in the last decade. 
Published data on the Tol system is scarce and is mostly based on E. coli and Pseudomonas with very limited 
studies on other species, namely Vibrio (Heilpern and Waldor, 2000; Salmonella (Prouty et al., 2002) and 
Haemophilus (Sen et al., 1996). The Tol system is commonly referred as Tol-Pal and Tol-OprL in E. coli and 
Pseudomonas, respectively. They are composed of seven proteins that are associated with different cellular 
compartments as shown below (Table 2.1): 
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Table 2.1 Tol system in E. coli and Pseudomonas sp. 
Location In E. coli In Pseudomonas sp. 
Outer membrane Pal OprL 
Periplasm TolB and YbgF  Tol B and Orf2   
Inner membrane TolQ, TolR, TolA TolQ, TolR, TolA 
Cytoplasm YbgC Orf1 
 
Sturgis (2001) investigated the distribution of the tol-pal gene cluster and found them in the genomes of 10 
different Gram negative bacteria. The gene cluster was not found in any Archaea, spirochete or Gram positive 
bacteria. Absence of the cluster in the Gram positive bacterial genomes implies their role in OM integrity and their 
absence in some Gram negative genomes indicates that the cluster is not universal. Interestingly, the structure of 
the tol-pal operon was similar in different species, wherein tolQ, tolR and tolA genes were easily identifiable (Fig 
2.2). 
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Figure 2.2 Organisation of the tol-pal genes cluster in different species (adapted from Sturgis, 2001).  
 
In spite of their existence in several Gram negative bacteria, the transcriptional organisation of these genes 
varies between different species, and in fact, it is seen to vary even within the same genus. Furthermore, in their 
review, Rodriguez-Herva and Llamas (2004) concluded that the failed attempts to determine the transcriptional 
initiation points of the tol-oprL (pal) promoters in E. coli and P. aeruginosa could be due to the low level of 
transcription and the instability or rapid degradation of the transcribed products. In E. coli, this system is organised 
into two operons, with YbgC, TolQ, TolR, TolA, TolB, Pal and YbgF forming the first operon and the second one 
from an inner promoter encoding TolB, Pal and YbgF (Fig. 2.2) (Vianney et al., 1996; Muller and Webster, 1997). 
On the other hand, in P. putida the tol-oprL genes are arranged in two transcriptional units, orf1-tolQ-tolR-tolA-
tolB and oprL-orf2 and in P. aeruginosa 3 units may occur; orf1-tolQ-tolR-tolA; tolB and oprL-orf2 (Rodriguez-
Herva and Llamas, 2004). The stoichiometry of the Tol-Pal complex is poorly-defined, although it is known that 
each gene is expressed at different levels. TolA and TolR abundance have been measured as about 600 (Levengood 
et al., 1991) and 2500 (Muller et al., 1993) copies per cell, respectively, and Pal is the most abundant with an 
 37 
estimate of 8000-40000 copies per cell (Sturgis et al., 2001). Guihard et al. (1994) estimated a ratio of 2.7: 1 
between TolQ to TolR. In P. aeruginosa, the number of amino acids and the molecular weight of TolQ, TolR and 
TolA are 231, 146, 346 and 25, 250; 15, 788; 37, 813 daltons, respectively, and sequence identity to E. coli TolQ, 
TolR and TolA were 53, 38 and 27%, respectively (Dennis et al., 1996). The expression of these tol-pal genes is 
tightly-regulated. For example, tolR is only expressed following the successful translation of tolQ, allowing the 
production of these proteins to be co-ordinated, which is relevant as they form a complex together (Muller et al. 
1993).  
 
 
 
Figure 2.3 Schematic representation of the various genes in the Tol system of E. coli showing their locations and 
transmembrane helices and the two operon structure (http://www.proteopedia.org/wiki/images/3/31/TOL.jpg) 
 
2.9.1. TolQ  
In E. coli, TolQ is an integral membrane protein of 25.5 kDa containing 230 amino acids with three 
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transmembrane helices and a large cytoplasmic domain between helices 1 and 2 (Fig. 2.3) (Sun and Webster, 
1987). Interactions within the cytoplasmic membrane have been found between TolQ and the other two integral 
membrane proteins, TolA and TolR. TolQ is mainly localised in the inner membrane and trace amounts can be 
present in the adhesion sites between the inner and outer membrane (Bourdineaud et al., 1989). The study by this 
group also revealed the direct involvement of the tolQ gene product in the entry of colicin A and that only a small 
amount of the TolQ protein was required for this purpose, wherein any excess protein was rapidly degraded. It has 
been demonstrated that the transmembrane domains of TolQ and TolR have structural and functional homologies 
not only to ExbB and ExbD of the TonB system but is also extended to MotA and MotB of the flagellar motor 
(Cascales et al., 2001).  
The P. aeruginosa TolQ has 53% homology to E. coli TolQ (Dennis et al., 1996) and is one of the most 
conserved proteins in Pseudomonads and other Gram negative bacteria. In this study, transcriptional analysis of the 
tol genes revealed that the tolQ and tolR genes are co-transcribed as an approximately 1.5-kb transcript in P. 
aeruginosa and that tolA is transcribed from its own promoter as an approximately 1.2-kb gene product. They also 
demonstrated that P. aeruginosa Tol proteins were functionally unable to complement E. coli tol mutants. In an 
earlier study, it was shown that the tolQ mutation had a strong polar effect on the expression of tolR (Vianney et 
al., 1996) and that TolR stability required the presence of TolQ (Cascales et al., 2001) and further, both TolQ and 
TolR proteins are essential for the TolA-Pal interaction. OM defects were noticed in tolQ mutants in terms of 
increased OM vesicle formation, RNaseI leakage and sensitivity to SDS and vancomycin (Cascales et al., 2001). 
 
2.9.2. Function of the Tol system 
The precise function of Tol proteins is unclear; however, they appear to be involved in maintaining the 
integrity of the cell envelope. Though it is known that the Tol import system plays some role in the translocation of 
certain biological macromolecules across the cellular membrane, the molecular interactions between these 
components is still unclear. Experiments have also shown that these proteins are required for single-stranded DNA 
 39 
filamentous bacteriophages to translocate DNA into the cytoplasm (Sun and Webster, 1987). Tol mutations have 
resulted in phenotypes hypersensitive to certain drugs and detergents, resistant to colicins, releasing periplasmic 
proteins (Lazdunski et al., 1998), and producing small OM vesicles (Bernadac et al., 1998). Studies also suggest 
that the Tol/Pal system might anchor the OM to the peptidoglycan layer (Clavel et al., 1998) and might catalyse 
porin biogenesis or regulate porin activity (Dover et al., 2000).  Mutation in the tolA gene caused changes in the 
LPS of P. aeruginosa cells making them more susceptible to aminoglycosides (Rivera et al., 1988) by increasing 
their affinity to the OM. The tolA gene was activated when P. aeruginosa biofilms were exposed to 
aminoglycosides, indicating their possible role in antibiotic resistance (Whiteley et al., 2001). In addition, tol-
minus E. coli cells could not separate into mother and daughter cells during cell division and formed long chains of 
cells (Bernadac et al. 1998) (Cascales et al., 2001) (Gerding et al., 2007). As Tol proteins may form some kind of 
trans-envelope bridge from outer to inner membrane, it has been proposed that Tol proteins may act to pull the 
outer and inner membranes together during cell division, as part of the invagination process (Gerding et al. 2007). 
In a recent study, Teleha et al. (2013) demonstrated the involvement of Tol proteins in cell division and over-
expression of TolQ resulted in an altered phenotype in E. coli cells (elongated and in long chains). The role of Tol-
Pal (OprL) system in the transport of various carbon sources across the cytoplasmic membrane has also been 
described in Pseudomonas and E. coli (Llamas et al., 2003). 
In conclusion, further insights in CHX tolerance in D. acidovorans can be examined using a combination of 
microscopic and molecular studies.
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3. MICROSCOPIC AND SPECTROSCOPIC ANALYSES OF CHLORHEXIDINE-TOLERANCE IN 
DELFTIA ACIDOVORANS BIOFILMS. 
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3.1. Abstract 
The physicochemical responses of Delftia acidovorans biofilms exposed to the commonly-used 
antimicrobial, chlorhexidine (CHX), were examined. A CHX-sensitive mutant (Minimum Inhibitory 
Concentration; MIC = 1.0 µg ml-1) was derived from a CHX-tolerant (MIC = 15.0 µg ml-1) D. acidovorans parent 
strain using transposon mutagenesis. Mutant (MT51) and wild-type (WT15) D. acidovorans biofilms were 
cultivated in flow cells and then treated with CHX at sub-MIC and inhibitory concentrations and examined by 
confocal laser scanning microscopy (CLSM), scanning transmission x-ray microscopy (STXM) and infrared (IR) 
spectroscopy. Specific morphological, structural and chemical compositional differences between the CHX-treated 
and untreated biofilms of both strains were observed. Apart from architectural differences, CLSM revealed a 
negative effect of CHX on biofilm thickness in the CHX-sensitive MT51 biofilms relative to the WT15 strain. 
STXM analyses showed that WT15 biofilms contained two morpho-chemical cell variants; whereas, only one type 
was detected in MT51 biofilms. Cells in MT51 biofilms bioaccumulated CHX to a similar extent as one of the cell 
types found in WT15 biofilms; whereas, the other cell type in WT15 biofilms did not bioaccumulate CHX. STXM 
and IR spectral analyses revealed that CHX-sensitive MT51 cells accumulated the highest levels of CHX. Pre-
treatment of biofilms with EDTA promoted accumulation of CHX in all cells. Thus, it is suggested that a sub-
population of cells that do not accumulate CHX appear responsible for greater CHX resistance in WT15 D. 
acidovorans biofilm in conjunction with the possible involvement of bacterial membrane stability. 
 
3.2. Introduction 
Antimicrobials are extensively used in clinical, domestic and industrial applications resulting in their 
continuous release into the environment, usually via sewage effluents. The presence of these compounds in the 
environment has led to concerns regarding selection of bacterial strains that have reduced susceptibility towards 
various kinds of antimicrobials (Fraise, 2002). Chlorhexidine (CHX) is a widely-used broad-spectrum 
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antimicrobial agent and its implications for microorganisms and the environment have received varying degrees of 
attention since its introduction (Lawrence et al., 2008). Chemically a cationic, hydrophobic and lipophilic 
bisbiguanide (C22H30Cl2N102C6H12O7), CHX is an active ingredient in many ‘daily-use’ disinfectants, antiseptics 
and pharmaceutical preservatives. CHX possesses broad antibacterial and antifungal activity. It reacts with 
negatively-charged phosphate groups on microbial cell walls causing membrane damage, enzyme inhibition and 
leakage of cytoplasmic constituents (Hope and Wilson, 2004). Extensive cell damage, coagulation of cytoplasmic 
constituents, and precipitation of proteins and nucleic acids can be expected when high concentrations (2%) of 
CHX are used due to the interactions between CHX and phosphorylated cytoplasmic molecules (Hope and Wilson, 
2004; Mohammadi and Abbott, 2009).  
Although several microbes have been reported to survive in the presence of in-use concentrations of CHX 
(Brooks et al., 2002, Marrie and Costerton, 1981, Stickler et al., 1987), little is known about the underlying 
mechanisms for this tolerance. Resistance to biocides is often referred to as tolerance (Favero, 2002). Biocides 
usually have multiple cellular targets and their effects are concentration dependent and often evaluated in terms of 
their ability to reduce the numbers of viable microorganisms. An earlier study indicated that CHX inhibits Gram-
positive and Gram-negative bacteria at concentrations of 1 mg L-1 and 2-2.5 mg L-1, respectively (Russell and Day, 
1993). However, MIC values for CHX vary depending on the type of bacteria, phenotypic and genotypic status of 
the organism and the environmental conditions. Tolerance levels could be much higher when microbes grow as 
biofilms (Hoiby et al., 2010; Mah and Toole, 2001). Biofilms are assemblages of microorganisms that form at 
interfaces, surrounded by self-produced extracellular polymeric matrices, typically attached to abiotic or biotic 
surfaces (Hoiby et al., 2010).  General mechanisms of antimicrobial resistance in biofilm bacteria have been 
described and discussed in scientific journals (Hoiby et al., 2010; Mah and Toole, 2001; Lewis, 2001). However, 
this literature largely consists of phenomenological descriptions of CHX resistance in biofilm communities rather 
than examining the specific mechanisms involved. Some bacterial genera (i.e., Proteus, Providencia) may either be 
intrinsically-resistant to CHX or have induced mechanisms of resistance due to phenotypic and genotypic changes 
(Russell, 1995). Penetration failure within biofilms, permeability characteristics of the cellular outer membrane 
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(Gilbert and Moore, 2005), CHX degradation (Tanaka et al., 2005) and the presence of resistance genes or 
plasmids have all been reported as possible causes for CHX resistance.  
Developments in microscopy have enabled researchers to develop a better understanding of biofilms and to 
study their interactions with various antimicrobials (Mangalappalli-Illathu and Korber, 2006; Neu et al., 2010; 
Vitkov et al., 2005). Microscopic techniques such as confocal laser scanning microscopy (CLSM), transmission 
electron microscopy (TEM) and scanning transmission X-ray microscopy (STXM) (Hitchcock, 2012) have been 
used singly, or in combination, to examine complex microbial communities and to map the extent, nature and 
distribution of macromolecules in a biofilm (Dynes et al., 2009; Lawrence et al., 2003). Cell viability, cell 
morphology, biofilm architecture and matrix composition can be studied in living, fully hydrated systems using 
CLSM (Lawrence et al., 2003; Korber et al., 1994). Fluorescent dyes such as SYTO9 and propidium iodide can be 
employed in combination with CLSM to evaluate the potential for antimicrobial agents to influence membrane 
integrity and permeability (20). The distribution and concentration of CHX in combination with 
biomacromolecules (e.g., proteins, lipids, polysaccharides) can be investigated using STXM at a spatial resolution 
of <30 nm in hydrated biofilm systems (Dynes et al., 2009; Dynes et al., 2006).  Sequences of images recorded 
over a span of photon energies at core excitation edges can be converted to quantitative maps of these compounds 
using suitable quantitative reference spectra. STXM at the C 1s edge has been exploited in several studies for 
mapping major biomacromolecules in biofilms (Dynes et al., 2009; Lawrence et al., 2003; Lawrence et al., 2012; 
Liu et al., 2013).  In addition, vibrational signatures of chemical bonds in biomolecules within a biofilm with a 
spatial resolution of <10 µm can be obtained using synchrotron radiation-based Fourier transformed infrared 
spectroscopy (SR-FTIR). Most of the relevant biological information can be obtained from the mid-infrared region 
(4000-800 cm-1).  Infrared absorption spectra of organic molecules provide unique “fingerprints” that can be 
applied for identification purposes with great reliability (Suci et al., 1998).  Bacterial biofilm changes that occur 
during: i) adaptation to their surrounding environments, ii) transportation, adsorption and interaction kinetics of 
antimicrobial agents within the biofilms (Holman et al., 2009; Susi et al., 2001; Suci et al., 1994), and iii) biofilm 
developmental stages (Quiles et al., 2010) have also been monitored using SR-FTIR.  
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Delftia acidovorans, formerly known as Comamonas acidovorans and Pseudomonas acidovorans, is a 
Gram-negative bacillus ubiquitously found in soil and water. Previously considered to be non-pathogenic, reports 
of D. acidovorans association with a number of serious infections, including bacteremia, empyema, bacterial 
endocarditis, ocular and urinary tract infections (Cho and Lee, 2002; del Mar Ojeda-Vargas et al., 1999; Horowitz 
et al., 1990; Perla and Kuntson, 2005), have been increasing, thus establishing this organism as an emerging 
opportunistic pathogen. Studies on the effects of antimicrobial agents on D. acidovorans biofilms are very limited 
and the available CHX literature has focused on either clinical isolates or dental biofilms. Thus, the effects on 
environmental D. acidovorans biofilms have never been reported.  
 In the present study, a combination of CLSM, STXM and SR-FTIR spectroscopy was applied to evaluate 
the effects of sub-MIC and inhibitory levels of CHX on CHX-tolerant and -sensitive D. acidovorans biofilms to 
elucidate intrinsic mechanisms of CHX resistance that may exist.   
 
3.3. Materials and methods 
3.3.1. Isolation, identification, mutant development and MIC determination  
The wild-type Delftia acidovorans (WT15) strain used in this study was isolated from South Saskatchewan 
River water biofilms during an earlier study on antimicrobial resistance (Mooney, 2006). The isolate was identified 
by a 16S rRNA gene sequencing protocol described elsewhere (Hirkala and Germida, 2004). Sequencing was 
carried out at the Plant Biotechnology Institute (PBI), National Research Council of Canada, Saskatoon, SK.  
Sequence identity was confirmed using Basic Local Alignments Search Tool (BLAST) and Ribosomal Database 
Project’s Sequence Match (RDP) comparing the obtained sequence to species with a greater than ≥ 99 % match. 
Mutants were created from the WT15 strain using the EZ-Tn5TM <KAN2> Tnp Transposome kit (Epicentre 
Biotechnologies, Madison, WI) following the supplier’s instructions and screened for sensitivity to CHX.   
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The gene interrupted by transposon (Tn5) insertion in D. acidovorans (MT51) was identified by the rapid 
amplification of transposon ends (RATE) technique, as described by Karlyshev et al. (2000). Amplified products 
were analysed by electrophoresis on a 1% agarose gel in 1X TAE buffer containing 0.5 µg ml-1 ethidium bromide. 
The product band was purified using the QIAquick Gel Purification kit (Qiagen, Mississauga, ON) as per the 
manufacturer’s instructions and then sent to the National Research Council of Canada, Saskatoon, Saskatchewan, 
Canada for sequencing. The gene disrupted by Tn5 insertion was identified as TolQ, a component of the TolQRAB 
gene cluster known to be involved in outer membrane stability in many bacterial species.  The sequence of the 
disrupted gene (tolQ) from WT15 was then compared with sequences published in the NCBI Nucleotide Database. 
The sequence data for TolQ was submitted to the GenBank database under accession number KT988307. TolQ has 
been shown to be an integral cytoplasmic membrane protein required for maintenance of the integrity of the 
bacterial envelope in E. coli (Vianney et al., 1994).  
The minimum inhibitory concentration (MIC), defined as the lowest concentration of CHX sufficient to 
inhibit the growth of the bacteria, was determined for the WT15 and selected mutants by the micro-dilution method 
(Andrews, 2001) using different concentrations of CHX dihydrochloride (Sigma Aldrich Co., St. Louis, MO).  The 
mutant (MT51) selected for this study had a CHX MIC = 1.0 µg ml-1, compared to a 15 µg ml-1 MIC for the WT15 
parent strain. 
 
3.3.2. Bacteria and culture conditions 
Delftia acidovorans (WT15 and MT51) strains were grown from frozen stock cultures stored in 10% 
(vol/vol) glycerol at -80°C (Kirsop and Snell, 1984) on Tryptic Soy Agar (TSA) plates and incubated overnight at 
room temperature (RT; 23±2° C).  A well-isolated colony was transferred to 50 ml of 1% of full strength (30 g L-1 
Tryptic Soy Broth (TSB) in an Erlenmeyer flask and incubated on a gyratory shaker (150±5 rpm) at RT until the 
mid-log phase of growth was reached (at approximately 14 h). This log phase culture was then used to inoculate 
the flow cells set up for the study. 
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3.3.3. Cultivation of biofilms for confocal laser scanning microscopy (CLSM) analysis 
Multichannel flow cells for CLSM biofilm analysis were constructed as previously described (Korber et al., 
1994). The flow cell apparatus was sterilized with 5.25% (wt/vol) sodium hypochlorite solution for at least 15 min 
and then flushed using sterile water followed by sterile growth medium (1% of full strength TSB or 100 times-
diluted normal TSB). Biofilms of WT15 and MT51 strains were cultivated by injecting 0.5 ml of log phase cells, 
prepared as outlined above, into each channel of the flow cell. During inoculation, the flow cells were left 
undisturbed for 30 min to facilitate attachment of the cells to the flow cell surface, after which pumping of the 
growth medium was resumed thereby washing out unattached cells.  Growth medium (1% TSB) was continuously 
pumped through each flow cell channel at a bulk flow rate of 25 ml h-1 (0.07 cm sec-1 laminar flow velocity) using 
a peristaltic pump (Watson Marlow 202U, Cornwall, UK) for 24 h. To evaluate the effect of CHX, established (24 
h) biofilms were then continuously treated for another 24 h period with sterile 1% TSB supplemented with either 0 
(Control), 10 µg ml-1 (sub-lethal) or 30 µg ml-1 (inhibitory) CHX. 
 
3.3.4. Cultivation of biofilms for STXM analysis 
Flow cells for STXM analysis were constructed as previously described (Dynes et al., 2006). Briefly, a 
silicon nitride window (Silson Ltd., Blisworth, UK) was placed between two glass microscope slides modified to 
accommodate inlet and outlet tubing, sealed with silicon adhesive and then the entire flow cell apparatus was 
sterilized by autoclaving. 
Inoculation and growth conditions (i.e., medium, pumping) were as outlined above. The biofilm cultivation 
period for STXM analysis was 12 h instead of the 24 h used in the CLSM study, as STXM analysis is limited to a 
maximum biofilm thickness of <10 µm. The 12 h biofilms were treated for a further 12 h with sterilized medium 
supplemented with either 0 or 10 µg ml-1 CHX, after which the windows were removed from the flow cells, air-
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dried and fixed to the STXM sample holder.  In a separate experiment, to examine the effect of inhibitory CHX 
concentrations, the 12 h (cultivation period) biofilms were treated with sterilized medium supplemented with 30 µg 
ml-1 and 100 µg ml-1 of CHX for 0.5 and 1 h.  The windows were then removed from the flow cells, air-dried and 
fixed to the STXM sample holder. To further study CHX accumulation over time, the 12 h biofilms on silicon 
nitride windows were treated with sterilized medium supplemented with 30 µg ml-1 of CHX and removed from the 
flow cells after 1 and 12 h of CHX exposure, air-dried and fixed to the STXM sample holder. 
Lastly, to investigate the effect of CHX on cell membrane-permeabilised biofilms, WT15 biofilms were 
grown for 12 h using sterilized medium supplemented with 1 mM ethylenediaminetetraacetate (EDTA), a known 
membrane permeabiliser, and then continuously treated for 12 h with sterilized medium supplemented with 10 µg 
ml-1 CHX, after which the windows were removed, air-dried and fixed to the STXM sample holder.  Untreated 
biofilms (no CHX) were compared as control. 
 
3.3.5. Cultivation of biofilms for IR spectroscopy 
The flow cell setup for IR analysis was similar to that used for STXM analysis except that the biofilms 
were grown directly on IR slides (Kevley Technologies, Chesterland, Ohio) with the internal reflection element as 
the substratum. Accordingly, the IR slide was sealed with silicone adhesive to a microscope glass slide having inlet 
and outlet ports. The flow cells were inoculated as described earlier, incubated under flowing conditions for 24 h 
and then treated with sterilized medium supplemented with either 0 (control), 10 or 30 µg ml-1 CHX, for an 
additional 24 h.  The IR slides with attached biofilms were then removed and air-dried prior to IR analysis.  
 
3.3.6. Confocal laser scanning microscopy and data analysis  
CLSM was used in conjunction with the BacLight LIVE/DEAD staining kit (Molecular Probes, Life 
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Technologies, Burlington, ON) i.e., Syto9 (live) and propidium iodide (dead) to quantify D. acidovorans viability 
in biofilms following 24 h CHX treatment, as follows. Flow cells were mounted on the stage of the confocal 
microscope and treated with of the LIVE/DEAD stain for 5 min in accordance with the manufacturer’s 
instructions. Optical thin sections were collected at 1 µm intervals from the attachment surface at five randomly-
chosen locations in each flow cell channel using a Bio-Rad MRC-1024 Lasersharp fluorescence scanning confocal 
laser system (Carl Zeiss MicroImaging GmbH, Jena, Germany). Dual-channel images, corresponding to 
fluorescence emission in the green (excitation/emission 488/522) (Syto9) and red (excitation/emission 535/617) 
(propidium iodide) wavelengths, were acquired in either the xy (as indicated above) or vertical xz planes. Digital 
image analysis (NIH image software, version 1.63f; National Institutes of Health, Bethesda, MD) of the optical thin 
sections was then used to determine cell viability and live/dead ratios (% fluorescence) at 48 h for both control and 
CHX-treated biofilms.  Biofilm thickness was measured in micrometers with the aid of a computer-controlled, 
motorized z-axis stepper motor and manual focusing with a Nikon Microphot-FXA microscope (Nikon Corp., 
Tokyo, Japan) (Neu et al., 2010). Average thickness values were calculated from 5 random fields for each biofilm, 
with thickness values measured at 5 separate locations per field. This analysis was experimentally replicated in 
triplicate for a total of 75 thickness measurements per treatment.  
 
3.3.7. Scanning transmission x-ray microscopy (STXM) and data analysis 
X-ray imaging and spectromicroscopy of biofilms prepared as described above were carried out using the 
STXM microscopes on beamlines 5.3.2.2 at the Advanced Light Source (ALS) (Berkeley, CA) (Kilcoyne et al., 
2003) and the SM beamline 10ID-1 at the Canadian Light Source (CLS) (Saskatoon, SK) (Kaznatcheev et al., 
2007).  Near edge X-ray fine structure absorption spectra (NEXAFS) were collected at the C 1s edge at a single 
energy, or as a sequence of energies (i.e., an 80 to 100 image stack) from 280 to 320 eV.  The raw transmitted 
signals were converted to optical densities (absorbances) using the incident flux signals measured at regions 
without biofilm, correcting for absorbance by the silicon nitride windows.  Quantitative component maps of the 
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major biomacromolecules (protein, lipid, polysaccharide) as well as CO32-, K+ and CHX, were derived by fitting 
the image sequences at each pixel to the spectra of reference compounds that had been placed on an absolute linear 
absorbance scale using the singular value decomposition procedure (Kirsop and Snell, 1984).  Absolute linear 
absorbance is the optical density (OD) per unit path length of a pure material of defined density, where the 
absorbance (A), also called OD, is given by A= OD = -ln(I/Io), where I = transmitted intensity and Io = incident 
intensity, and is established by adjusting the intensity scale of the reference spectrum to that of the computed 
elemental response outside the structured near edge region (Dynes et al., 2006). The lower and upper limits of the 
gray scale indicated in the component maps are a measure of the component thickness in nm. The reliability and 
methodology used to quantitatively map the major biomacromolecules in biofilm cells has been described in detail 
elsewhere (Hitchcock, 2012; Dynes et al., 2006; Dynes et al., 2006). The reference compounds used were protein 
(human serum albumin), lipid (1, 2-dipalmitoyl-sn-glycero-3-phosphocholine), polysaccharide (xanthan gum), 
carbonate (calcite), K (K2CO3 with CO3 derived from Ca carbonate subtracted) (Korber et al., 1994; Dynes et al., 
2009) and chlorhexidine dihydrochloride (CHX). The microscope energy scale was calibrated to ± 0.05 eV 
accuracy using the Rydberg peaks of CO2. The analysis was carried out using Axis2000 software (Hitchcock, 
2014).  
 
3.3.8. Infrared spectroscopy and data analysis  
Air-dried 48 h CHX-treated and control biofilms were analyzed using the Mid Infrared Spectromicroscopy 
(Mid-IR) Beamline 01B1-1 at the Canadian Light Source, Saskatoon, using a Bruker Optics IFS66v/s FTIR 
spectrometer and a Hyperion 2000 IR microscope. The slides were mounted on the microscope and the area to be 
analysed was focused, after which the chamber was tightly-closed and flushed with nitrogen gas for at least 15 min 
to minimize CO2 and water vapour interference. The instrument was operated using the following settings:  
reflectance mode, phase resolution of 32 cm-1, scanner velocity of 8, 40.0 KHz and an aperture size of 12 µm x 12 
µm (±3 µm). The samples were scanned over a wide spectral range i.e., from 4000 cm-1 to 800 cm-1. Single point 
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background scans (n=5000) were taken on the IR slide that was free of biofilm material to establish the background 
noise level. The biofilm samples were scanned at 24 different points 256 times each at 4 cm-1 resolution. The 
reference spectrum was developed by dissolving a small quantity of CHX dihydrochloride in distilled water 
followed by spreading and drying as a thin layer on the IR slide and scanning at a single point (n=128, 4 cm-1 
resolution). All the spectra were derived and analysed using the OPUS software (Bruker Optic Inc., Billerica, MA). 
 
3.4. Results 
3.4.1. CLSM analysis of CHX-treated D. acidovorans biofilms 
CLSM was used to visualize the baseline biofilm structure, thickness and cell viability in the presence (10 
and 30 µg ml-1) and absence of CHX.  Both the CHX-tolerant WT15 and CHX-sensitive MT51 strains attached to 
the glass surfaces of flow cells and developed into biofilms within 24 h in the absence of CHX, after which they 
were exposed to CHX. The average thickness of untreated MT51 biofilms after 48 h was 31.3 ± 9 µm compared to 
16.33±4.3 µm for the untreated WT15 biofilms (Table 3.1).  When the 24 h WT15 and MT51 D. acidovorans 
biofilms were treated with TSB supplemented with 10 µg ml-1 CHX for an additional 24 h, the mutant biofilm 
thickness was significantly (P<0.05) reduced to 13.2 µm; whereas, the wild type biofilm increased in thickness by 
2 µm. When a concentration of 30 µg ml-1 CHX was applied for the same exposure period, the WT15 biofilm 
ceased to grow whereas MT51 biofilm cells were virtually all detached from the glass surface and washed out.  
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Table 3.1 Thicknesses of treated (10 and 30 µg ml-1 CHX) and control WT15 and MT51 D. acidovorans biofilms 
as determined using CLSM. Values are the mean (±SD) of 3 separate experiments. Values followed by the same 
letters are not significantly different at P <0.05. 
 
 
 
 
 
 
Differences were also seen in the architecture of CHX-treated and untreated biofilms. Figs. 3.1A and 3.1C 
show typical CLSM images of 48 h control WT15 and MT51 biofilms, respectively; the WT strain grew as 
spatially-isolated, individual microcolonies consisting of relatively densely-packed cells.  In accordance with this 
heterogeneous architecture, the thickness of the WT15 biofilm was variable throughout the flow channel. In 
contrast, the MT51 biofilm consisted of uniformly distributed cells enclosed within an extensive extracellular 
polymeric substance (EPS) matrix (31.3±9.0 µm). Following 24 h exposure to CHX at 10 µg ml-1 CHX, the 
biofilm matrices appeared similar in both cases; the WT15 biofilms underwent a shift in microcolony structure and 
became more homogenously distributed like the MT51 biofilms (Figs. 3.1B and 3.1D). Individual cells within the 
biofilm could be more clearly seen after MT51 biofilms were exposed to CHX and they appeared to be less dense 
than the WT15 biofilms.  
 
Biofilm type Average thickness (µm) 
WT15 control 16.33±4.3 B 
WT15 treated (10  µg ml-1) 18.0±6.4 B 
WT15 treated (30  µg ml-1) 16.0±3.3 BC 
MT51 control 31.3±9.0 A 
MT51 treated (10  µg ml-1) 13.2±7.0 CD 
MT51 treated (30  µg ml-1) 8.36±3.9 D 
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Figure 3.1 CLSM images obtained from the 5 µm sectioning depth of 48 h treated (10 µg ml-1 CHX) and untreated 
WT15 and MT51 D. acidovorans biofilms stained with BacLight Live/Dead stain. Biofilms were grown for 24 h 
using 1% TSB and then cultivated for an additional 24 h in the presence or absence of 10 µg ml-1 CHX. (A) WT15 
control, (B) WT15 treated, (C) MT51 control, and (D) MT51 treated biofilms. Green represents viable cells; red 
non-viable cells.   
 
 SYTO9 and propidium iodide staining was used to determine the proportion of live and dead cells in 
WT15 and MT51 biofilms grown in the presence and absence of CHX. The vertical distribution of living cells 
within the first 20 µm of the biofilms after 48 h growth is illustrated in Fig. 3.2. Untreated biofilms consisted of 98-
99% viable cells throughout the vertical profile in the case of both WT15 and MT51 biofilms. However, the mean 
viability of both WT15 and MT51 biofilms decreased following 10 and 30 µg ml-1 CHX treatment relative to 
untreated control biofilms. In the presence of 10 µg ml-1 CHX the proportion of viable cells in the WT15 biofilm 
increased with distance from the attachment surface over the entire thickness examined, in agreement with an 
increase in overall biofilm thickness, as illustrated in Table 3.1. In contrast, no definite pattern was observed for the 
WT15 biofilms exposed to 30 µg ml-1 CHX treatment. In the case of the MT51 strain, total viable cells decreased 
significantly (P<0.05) with depth following both 10 and 30 µg ml-1 CHX treatment compared to the MT51 control 
biofilm.  
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Figure 3.2 Viability profiles of 48 h WT15 and MT51 D. acidovorans biofilms grown for the last 24 h in the 
presence or absence of CHX (10 and 30 µg ml-1). Determinations were made by analyzing CLSM optical thins 
sections of BacLight Live/Dead stained-biofilms obtained at the 0, 5, 10, 15 and 20 µm sectioning depth (where 0 
µm = attachment surface).   
 
3.4.2. Soft X-ray scanning transmission microscopy (STXM) 
The reference spectra used to derive the quantitative component maps for CHX and the major 
macromolecules in Delftia acidovorans biofilms, including protein, lipids, polysaccharides, carbonate, and K, have 
been published previously (Dynes et al., 2006) and discussed in detail (Dynes et al., 2009; Lawrence et al., 2003; 
del Mar Ojeda-Vargas et al., 1999). STXM images were collected at 288.2 eV for the MT51 and WT15 biofilms 
exposed to 0 (control) and 10 µg ml-1 CHX for 12 h (after 12 h of initial growth without CHX) (Fig. 3.3). Since 
bacteria are roughly composed of 50% protein, this photon energy is useful for preferentially visualizing bacterial 
cells, as it is mainly due to the absorption of the carbonyl moiety in the peptide band ((NH2)-C=O) of proteins 
(Dynes et al., 2006). The optical density is indicated by the gray scale, with white and black, corresponding to 
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higher and lower thicknesses of protein respectively. In the absence of CHX, the protein in the WT15 cells was not 
evenly distributed as evidenced by the wide variation in the optical density (Fig. 3.3A); whereas, there was no 
variation in the optical density of the cells/protein in the MT51 control system, with all being white (i.e., thickest) 
(Fig. 3.3B). Exposing the WT15 biofilms to CHX resulted in some of the cells having greater amounts of protein 
(Fig. 3.3C), suggesting that there were two different cell types, based on their response to CHX. There was no 
apparent change in the optical densities of the MT51 cells when exposed to CHX (Fig. 3.3D). Fig. 3.4 presents the 
quantitative protein, lipid and polysaccharide component maps derived from spectral fitting of 24 h-old WT15 
control biofilms (obtained from the same region as for the 288.2 eV image, Fig. 3.3A). The gray scale shown in the 
component maps are a measure of the component thickness in nm, with the lower (black) and upper (white) limits 
of the scale shown for each component. The color-coded composite image (Fig. 3.4D) shows the spatial correlation 
of the components. No CHX signal was detected in the control biofilms. There was variation in the protein, lipids 
and polysaccharides content within individual cells, consisting of areas with relatively high and low content.  
The quantitative protein, lipids, polysaccharides and CHX component maps for the 24 h-old WT15 biofilms 
exposed to 10 µg ml-1 CHX for 12 h (after 12 h of initial growth without CHX) are shown in Fig. 3.5. From the 
protein component map there were cells whose protein was unevenly distributed similar to that of the control 
biofilm (Figs. 3.4A,D), however, there were also cells where the protein was higher in concentration and was 
evenly distributed (see arrows, Fig. 3.5A). This suggests that there were two cell types in these WT15 biofilms. 
The cells with high protein levels also had high lipid and polysaccharide content but there was variation in their 
lipid and polysaccharide levels within the cells.  In contrast, the lipid and polysaccharide content was fairly evenly 
distributed in the cells with the low lipid and polysaccharide levels. All CHX-treated cells contained CHX, with the 
highest level of CHX contained by cells with high protein, lipid and polysaccharide levels.  Moreover, the spatial 
pattern of CHX distribution in the cells with high CHX content was similar to that of the lipid and polysaccharide 
spatial pattern. 
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Figure 3.3 Optical density images (288.2 eV) represents the carbonyl of the protein in microbial cells) of CHX-
treated (10 µg ml-1 for 12 h) and control biofilms of CHX-tolerant (WT15) and CHX-sensitive (MT51) D. 
acidovorans strains after 24 h of growth. (A) WT15 control, (B) MT51 control, (C) WT15 CHX-treated, and (D) 
MT51 CHX-treated.  Arrows indicate the two cell types observed in the biofilms as evident from the density/ 
distribution of the protein in the cell. The gray scales indicate optical density. 
 
Figure 3.4 Component maps of 24 h CHX-tolerant (WT15) D. acidovorans biofilms not exposed to CHX.  (A) 
Protein, (b) Lipid, and (c) Polysaccharide (Sacc).  Maps (A–C) were derived by singular value decomposition 
(SVD) of an image sequence (280–320 eV).  The gray scales indicate the effective thickness of the mapped 
component in nm.  Color-coded composites of selected component maps (D) Protein=red, lipid=green, 
polysaccharide=blue.   
 
 56 
 
Figure 3.5 Component maps of 24 h CHX-tolerant (WT15) D. acidovorans biofilms treated with CHX (10 µg ml-1 
for 12 h). (A) Protein, (B) Lipid, (C) Polysaccharide (Sacc), and (D) Chlorhexidine (CHX).  Maps (A–D) were 
derived by singular value decomposition (SVD) of an image sequence (280–320 eV).  The gray scales indicate the 
effective thickness of the mapped component in nm. Color-coded composites of selected component maps (E) 
Protein=red, lipid=green, polysaccharide=blue, and (F) protein=red, lipid=green, polysaccharide=CHX.  The 
arrows in (A) indicate the two cell types observed in the biofilm.  
 
The quantitative protein, lipids, polysaccharides and CHX component maps for the 24 h-old MT51 biofilms 
exposed to 10 µg ml-1 CHX for 12 h (after 12 h of initial growth without CHX) are shown in Fig. 3.6.  Only one 
cell type, with even distribution of CHX, protein and lipid but not polysaccharide, was observed in all cells. The 
spatial distribution of CHX was different from WT15-treated cells, as in this case the pattern was similar to that of 
protein and lipid, rather than lipid and polysaccharide as seen in WT15 cells. The spectral curve fitting of CHX 
(Fig. 3.6) was performed by extracting a CHX-rich region from the image sequence to include only pixels with a 
value of more than 100 nm. The numerical values extracted from the spectral fit data were protein (albumin)- 95.3 
nm, lipid ((1,2-dipalmitoyl-sn-glycero-3-phosphocholine)- 55.3 nm, polysaccharide (xanthan gum)- 42.0 nm, and 
CHX-135 nm. 
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Figure 3.6 Component maps of 24 h CHX-sensitive (MT51) D. acidovorans biofilms treated with CHX (10 µg ml-
1 for 12 h). (A) Protein, (B) Lipid, (C) Polysaccharide (Sacc), and (D) Chlorhexidine (CHX). Maps (A–D) were 
derived by singular value decomposition (SVD) of an image sequence (280–320 eV).  Color-coded composites of 
selected component maps (E) Protein=red, lipid=green, polysaccharide=blue, and (F) protein=red, lipid=green, 
polysaccharide=CHX.  The gray scales indicate the effective thickness of the mapped component in nm. Curve fit 
to the spectrum extracted from CHX component map with pixels having values more than 100 nm is also shown. 
 
The levels of CHX in the cells from 10 µg ml-1 treated WT15 and MT51 biofilms were then compared 
(Figs. 3.5 and 3.6), and the WT15 cells accumulated CHX to a maximum thickness value of 115 nm. Whereas, 
CHX-exposed MT51 cells accumulated CHX to a thickness of almost twice this value. This finding is further 
supported by the concentration values calculated on a per pixel basis, as presented in Table 3.2, where the 10 µg 
ml-1 CHX-treated MT biofilms accumulated five times (94.1 ±58.3 nm) more CHX than the 10 µg ml-1 CHX-
treated WT biofilms. 
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Table 3.2 Average thickness values (in nm) of CHX in WT15 and MT51 CHX-treated biofilms as determined 
from STXM images. All treatments were carried out on 12 h established biofilms. 
Biofilm CHX 
nm per pixel (± Standard Deviation) 
WT15 (10 µg ml-1 for 12 h) 17.4 ± 19.6 
MT51 (10 µg ml-1 for 12 h) 94.1 ± 58.3 
EDTA exposed WT15  (10 µg ml-1 for 12 h) 36.5 ± 34.8 
WT15 (30 µg ml-1 for 1 h) 17.2 ± 21.2 
MT51 (30 µg ml-1 for 1 h) 58.9 ± 43.3 
WT15 (30 µg ml-1 for 12 h) 73.2 ± 42.3 
MT51 (30 µg ml-1 for 12 h) 101.0 ± 52.5 
 
The effect of higher concentrations of CHX was studied only for the CHX-tolerant, WT15 D. acidovorans 
biofilms by exposing 12 h-old WT15 biofilms to 30 and 100 µg ml-1 of CHX for 30 and 60 min. In agreement with 
results obtained at lower concentration at 10 µg ml-1, two different cell variants were seen at both CHX 
concentrations, as well as after both exposure times. However, the majority of the cells appeared lighter in the 
biofilms treated with 100 µg ml-1 CHX (Fig. 3.7) than those treated with 30 µg ml-1for one hour.  
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Figure 3.7 Optical density images (288.2 eV, represents the carbonyl of the protein in microbial cells) of CHX-
tolerant (WT15) D. acidovorans biofilms grown for 12 h before treatment with (A) 30 µg ml-1 and (B) 100 µg ml-1 
CHX for 1 h. The arrows indicate the two cell types observed in the biofilm.  
 
Based on the above results, the effect of short (1 h) and long (12 h) CHX (30 µg ml-1) exposure times was 
evaluated on both 12 h WT15 and MT51 biofilms. Fig. 3.8 shows a time-dependent effect, wherein the MT51 cells 
accumulated more CHX over time relative to CHX-tolerant WT15 cells. In comparison, CHX intensity (blue color) 
was less in CHX-tolerant cells even after 12 h of exposure. This observation was further substantiated by Table 3.2 
which quantifies the differences in CHX accumulation between CHX-sensitive and CHX-tolerant cells exposed to 
above-MIC (30 µg ml-1) CHX concentrations at both time intervals.  Interestingly, both cell variants, described 
earlier, were seen in 1 h treated WT15 and MT51 biofilms but only the dark/dense cells were seen after long term 
exposure (12 h) to CHX. The 1 h STXM images were further examined in detail and showed that the denser cells 
had higher levels of CHX than the lighter cells within the same biofilm for both strains (Fig. 3.9 and Table 3.3). 
There was not much difference in CHX concentration among the light cells in both cases, but the darker cells 
within the MT51 CHX-treated biofilms had nearly twice as much CHX as their WT counterparts (Table 3.3).  
There was variation in concentration of other macromolecules as well between the dark and light cells in both 
WT15 and MT51 biofilms (Table 3.3), with denser cells containing primarily more protein followed by lipid and 
polysaccharide.  The spatial distribution of CHX in 1 h CHX-exposed cells (Fig. 3.8) indicated that CHX was 
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initially associated with the lipid component of the cells; however, this effect was difficult to confirm with 
increasing CHX-exposure time, especially for the MT51 biofilms.  
 
Figure 3.8 Color coded composites (protein=red, lipid=green, CHX=blue) of CHX-tolerant (WT15) and CHX-
sensitive (MT51) D. acidovorans biofilms grown for 12 h before treatment with 30 µg ml-1 CHX for 1 h (A and C) 
and 12 h (B and D), respectively.  
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Figure 3.9 Intensity profiles extracted from a section of the dark and light microbial cells from the protein (red), 
lipid (green), polysaccharide (blue) and CHX (pink) component maps from Figure 8 of the WT15 and MT51 D. 
acidovorans biofilms grown for 12 h before treatment with 30 µg ml-1 CHX for 1 h.  The figures are 288.2 eV 
transmission images.  The red and green rectangles show the area from which the profiles for the dark and light 
cells were taken, respectively. The gray scales indicate optical density. 
 
Table 3.3 Average thickness values (in nm) of major macromolecules of the two cell types of 12 h established 
WT15 and MT51 biofilms exposed to 30 µg ml-1 CHX for 1 h, as determined from STXM images. 
Cell type Protein Lipid  Saccharide CHX 
nm per pixel (± Standard Deviation) 
WT15-dense 148.0 ±19.3  69.7 ± 13.6 75.2 ± 18.0  45.5 ± 14.2 
WT15-light 111.0 ± 20.2 45.1 ± 12.6  62.2 ± 15.0  6.92 ± 7.34 
MT51-dense 141.0 ± 28.9 72.2 ± 20.4  61.4 ± 13.6 107.0 ± 30.9 
MT51-light 95.5 ± 15.9  38.4 ± 9.28  52.3 ± 9.65 15.0 ± 8.61 
 
To further investigate CHX accumulation effects, WT15 biofilms were first exposed to the membrane 
permeabilising agent, ethylenediaminetetraacetic acid (EDTA), before exposure to 10 µg ml-1 CHX.  Figs. 3.10 and 
3.11 show the component maps of WT15 biofilm cells exposed to EDTA only and EDTA followed by CHX 
treatment. As shown in Table 3.2, treatment with EDTA promoted bioaccumulation of CHX (almost double) in 
WT15 biofilms (36.5 ± 34.8 nm per pixel) than WT15 biofilms treated only with CHX (17.4 ± 19.6 nm per pixel). 
Furthermore, only one type, the darker cells that accumulated CHX in our earlier studies, were found to be present 
in the EDTA treated biofilms (Fig. 3.11).  
 62 
 
Figure 3.10 CHX-tolerant (WT15) D. acidovorans biofilms treated with 1 mM EDTA for 24 h. (A) Optical density 
(OD) image (288.2 eV).  The gray scale indicates OD. The white dotted rectangle shows the microbial cell studied 
in detail. Component maps of the microbial cell (B) Protein, (C) Lipid and (D) Polysaccharide (Sacc) and a color-
coded composite (E) of the selected component maps (protein=red, lipid=green, polysaccharide=blue).  Maps (B–
D) were derived by singular value decomposition (SVD) of an image sequence (280–320 eV).  The gray scale (B-
D) indicates the effective thickness of the mapped component in nm.  EDTA could not be detected in, or near, the 
microbial cell. 
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Figure 3.11 CHX-tolerant (WT15) D. acidovorans biofilms treated with 1 mM EDTA and 10 µg ml-1 CHX. (A) 
Optical density (OD) image (288.2 eV).  The gray scale indicates OD. The white dotted rectangle shows the 
microbial cell studied in detail. Component maps of the microbial cell (B) Protein, (C) Lipid, (D) Polysaccharide 
(Sacc), (E) CHX, and (F) EDTA. Maps (B–D) were derived by singular value decomposition (SVD) of an image 
sequence (280–320 eV).  The gray scale (B-D) indicates the effective thickness of the mapped component in nm. 
Color-coded composites of the selected component maps (G) Protein=red, Lipid=green, Polysaccharide=blue, and 
(H) Protein=red, EDTA=green, CHX=blue. 
 
3.4.3 Infrared Spectroscopy 
Specific IR absorption patterns can be attributed to particular types of covalent bonds and any 
modifications of these bonds by the local environment can be detected in the details of the IR spectra. Accordingly, 
vibrational signatures of organic molecules in microbial biofilms can be measured using IR spectromicroscopy.  
The main absorption bands of biofilms correlating with the experimental conditions employed in this study are 
plotted in Fig. 3.12A, with the IR spectrum of the CHX standard provided for reference. The subset panel of IR 
spectra reveals a peak at around 1492 cm-1 which is attributed to the chlorophenol groups of CHX (Holman et al., 
2009). Two peaks at the 3400 cm-1 region were also seen in the CHX IR spectrum and could be attributed to υυas 
and υυas- NH, which is also suggestive of CHX (Cortes et al., 2001). Peaks were also observed in 1650, 1600, 
1550 and 1500 cm-1 that can be attributed to the C=C stretching of the aromatic moiety of CHX (Cortes et al., 
2001).  The peak at 1492 cm-1, enlarged in Fig. 3.12B, was very prominent in CHX-sensitive, MT51 biofilms 
treated with 10 and 30 µg ml-1 CHX, with the peak area being larger in biofilms receiving the latter treatment. In 
contrast, the CHX diagnostic peak at 1492 cm-1 was absent in the control biofilms without CHX.  
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Figure 3.12 IR spectra obtained for WT15 and MT51 D. acidovorans biofilms not exposed to CHX for 48 h and 
CHX-treated WT15 and MT51 D. acidovorans biofilms (10 and 30 µg ml-1 for 24 h).  (A) 1000 to 4000 cm-1 and 
(B) expansion of (A) from 1450 to 1600 cm-1. WT15 and MT51 control biofilms multiplied by 5 and CHX treated 
biofilms multiplied by 2.  
 
3.5. Discussion 
Association of Delftia spp. with antibiotic resistance phenomena has been referenced in the literature but 
overall is very limited (Ravaoarinoro and Therrien, 1999; Chotikanatis et al., 2011; Stampi et al., 1999). To our 
knowledge, this is the first report of D. acidovorans tolerance to a broad spectrum biocide such as CHX. Several 
strains of C. acidovorans isolated from clinical specimens have been found to be resistant to various groups of 
antibiotics such as β-lactams, aminoglycosides and quinolones (Ravaoarinoro and Therrien, 1999). Chotikanatis et 
al. (2011) summarized the antibiotic susceptibilities of D. acidovorans reported in the past and concluded that all 
were resistant to gentamicin, some to all aminoglycosides and generally susceptible to cephalosporins, piperacillin, 
aztreonam, carbapenems, quinolones, and trimethoprim-sulfamethoxazole. A positive correlation between C. 
acidovorans and residual chlorine was found in contaminated dental water units, indicating a strong resistance of 
this bacterium to chlorine (Stampi et al., 1999). Additionally, a D. acidovorans strain isolated from a wastewater 
treatment facility was found to carry class 3 integrons, genetic elements commonly-associated with antibiotic 
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resistance genes. This finding added a new role for this group of organisms in the acquisition of resistance genes 
from antibiotic-resistant microbes in the environment (Xu et al., 2007).  
The MIC levels for CHX have been tested for many bacterial species and the range of tolerance is very 
large and dependent on factors such as type of bacteria (Gram-positive or Gram-negative), method or media used, 
etc. In a recent study (Valenzuela et al., 2013), CHX exhibited the greatest variability with MIC’s in a range from 
2.5 to 2,500 mg ml-1 when 272 Enterococcus strains were tested for sensitivity to biocides of different classes 
(quaternary ammonium compounds, a bisphenol, a biguanide and copper sulfate). Similarly, the MIC of CHX for 
52 strains of subgingival plaque (biofilm) bacteria ranged from 8 to 500 µg ml-1 (Stanley et al., 1989); whereas, for 
methicillin-resistant Staphylococcus aureus isolates collected over 15 years, the MIC range was found to be 0.5 to 
16 µg ml-1 (Wang et al., 2008).  The MIC of four common human pathogens, Escherichia coli, Klebsiella 
pneumonia, Pseudomonas aeruginosa and Staphylococcus epidermidis were 0.008, 0.0625, 0.125 and 0.002 µg ml-
1, respectively (Houari and Martino, 2007), and MICs varied between 1-20 µg ml-1 for various Gram-positive and 
Gram-negative oral bacteria examined (Susi et al., 2001). Based on comparison of the chlorhexidine MIC value for 
WT15 D. acidovorans (15 µg ml-1) with MIC values from other reported studies, WT15 can be considered as 
“tolerant” to CHX.  
While both the WT15 and MT51 D. acidovorans strains used in this study were demonstrated to form 
biofilms, the MT strain formed thicker biofilms than the WT in the absence of CHX. The biofilm structure, in 
terms of cell distribution and density, was also different between WT15 and MT51 strains (Fig. 3.1). The reason 
for this difference may be related to fitness costs associated with CHX tolerance as a result of the Tn5 mutation. 
Previous studies have demonstrated that the cost associated with chromosomal resistance will vary profoundly 
depending on the growth and experimental conditions used (Andersson and Levin, 1999). The relative fitness of 
susceptible and resistant bacteria is measured by their reproductive success during in vitro culture. Many studies 
have reported that resistance commonly creates a fitness burden (Andersson and Levin, 1999; Andersson and 
Hughes, 2010); however, resistant mutants with no measurable costs or those with a slight advantage over wild 
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type have also been observed (Bjorkman et al., 1998; Miskinyte and Gordo, 2013), which is in agreement with our 
observations.  However, in the presence of CHX at 10 µg ml-1, the biomass of the WT15 biofilms increased over a 
24 h period; whereas, there was an apparent cessation of biofilm development in the CHX-treated MT51 biofilms 
compared to their untreated counterparts. It is also possible that exposure of MT51 cells to CHX could result in 
dispersal of biomass contributing to an apparent reduction in biofilm thickness of MT51 biofilms. Such stimulation 
of biofilm development, as seen in the WT15 biofilm in the presence of sub-MIC concentration of CHX, has 
previously been reported (Hope and Wilson, 2004). In addition to the change in overall biofilm thickness observed 
in our study, the form and arrangement of microcolonies in both types of biofilms became altered upon exposure to 
CHX.  The cells in control WT15 biofilms were arranged in very close association with each other, but upon 
exposure to CHX, these distinct microcolonies ceased to be evident. Hope and Wilson (2004) observed biofilm 
contraction when 0.2% CHX was used on plaque biofilms (Hope and Wilson, 2004), attributing this to ionic 
interactions between the negatively-charged EPS matrix and the positively-charged CHX molecules. They reported 
that these interactions changed the EPS solubility, hydrophobicity and net charge of the matrix, thus reducing the 
repulsive forces between charged moieties and allowing the biofilm matrix to contract. However, at 0.05% CHX 
exposure, the contraction was not significant and non-uniform and hence they concluded that biofilm contraction 
may be related to the concentration of CHX as well.  
Since CHX effects include bacterial membrane damage (Gilbert and Moore, 2005; Vitkov et al., 2005; 
Barrette-Bee et al., 1994), its bactericidal action can be measured using the BacLight LIVE/DEAD stain (Hope and 
Wilson, 2004, Dynes et al., 2009; Shen et al., 2009; von Ohle et al., 2010) that is sensitive to the permeability of 
the cytoplasmic membrane.  Upon CHX treatment the percentage of viable cells, based on maintaining selective 
membrane permeability, decreased in both WT15 and MT51 biofilms (Fig. 3.2) to varying degrees. The proportion 
of viable cells in the WT15 biofilm increased in the presence of 10 µg  ml-1 CHX from the base of the biofilm (the 
attachment surface) to biomass located further away from the attachment surface (and closest to the bulk liquid 
phase containing CHX). This is in agreement with an increase in biofilm thickness in the presence of CHX (Table 
3.1).  In contrast to WT15 biofilms, a gradual loss of green fluorescence, indicative of a reduction of “living cells” 
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was observed beginning at the biofilm-liquid interface in MT51 biofilms exposed to CHX. MT51 cells in direct 
contact with CHX were affected by the biocide to a greater extent than cells located deep within the biofilm matrix. 
These affected cells may have subsequently become detached from the biofilm base, an occurrence consistent with 
the observed reduction in biofilm thickness in MT51 biofilms upon CHX treatment. These results are also in 
agreement with other studies (von Ohle et al., 2010; Pratten et al., 1998; Takenaka et al., 2008) where similar 
patterns of viability were observed in biofilm cells exposed to CHX. However, we did not see a complete 
eradication of the biofilms at either concentration of CHX (10 µg ml-1 or 30 µg ml-1) used in this study. 
Interestingly, low numbers of MT51 cells continued to persist even at 30 µg ml-1, a value thirty times the MIC for 
planktonic cells (1 µg ml-1), which is in agreement with the paradigm that biofilm growth renders cells 10 to 1000 
times more resistant than their planktonic counterparts (Hoiby et al., 2010; Mah and Toole, 2001). 
Confocal microscopy demonstrated the effect of CHX on MT51 and WT15 biofilms; however, there was a 
need to map the spatial distribution and uptake of CHX to understand the differences in CHX tolerance in these 
two strains. Dynes et al., 2006 were the first to observe the bio-accumulation of CHX in lipid-rich regions of 
diatoms and bacteria using STXM to study CHX-exposed river biofilms. In the present study using STXM, 
bioaccumulation of CHX was similarly also seen in D. acidovorans WT15 and MT51 biofilms, although to 
different extents. A significant question arises as to whether all cells in the WT15 biofilm exhibited the same level 
of tolerance, or whether there was a sub-population that existed as “persister” cells (Lewis, 2001; Keren et al., 
2004) and were able to tolerate CHX. We thus suggest that the WT15 Delftia biofilms contains two populations (as 
shown in Figs. 3.3, 3.7, 3.9); those that apparently do not, or only slowly, take up CHX (light cells) and those that 
do (dark cells), with the former being responsible for persistence and tolerance within WT15 biofilms. STXM 
mapping results showed that CHX was distributed throughout the cell and could not be linked to any particular 
cellular macromolecule or region.  As well, the MT51 biofilm cells accumulated five times the amount of CHX as 
did the WT15 cells, in agreement with their increased sensitivity to CHX (Table 3.2). When the WT15 biofilms 
were exposed to higher CHX concentrations (30 µg ml-1 and 100 µg ml- 1), the number of dark cells increased 
accordingly. The apparent absence of light cells in 100 µg ml-1 CHX-exposed WT15 biofilms indicates that 
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intrinsic CHX tolerance tends to decrease at CHX concentrations greater than 30 µg ml-1. Temporal analysis of 
biofilm cells treated with 30 µg ml-1 also revealed that the MT51 cells accumulated more CHX than the WT15 
strain over a 1 h period, indicating an immediate effect of CHX on the sensitive cells. Interestingly, examination of 
1 h CHX-exposed (30 µg ml-1) biofilm cells revealed the association of CHX with cellular lipids (Fig. 3.8); 
whereas, at lower CHX concentration (10 µg ml-1) no association of CHX with any particular cellular component 
could be established  (Fig. 3.5). This finding is consistent with other reported observations (Dynes et al., 2006; 
Castillo et al., 2004; Elferink and Booij, 1974) where associations between CHX and lipids were made. This is also 
consistent with the fact that CHX is a positively-charged hydrophobic, lipophilic molecule which interacts with 
negatively-charged lipopolysaccharide molecules of the bacterial outer membrane before being able to enter into 
the cell.  
Our observations of the presence of two different kinds of cells within the CHX-exposed WT biofilms is 
supported by similar work (Tattawasart et al., 2000) where energy-dispersive analysis of X-ray (EDAX) mapping 
revealed differences in CHX uptake between CHX-sensitive and resistant isolates of Pseudomonas stutzeri. In this 
work, X-ray fluorescence signals of chloride (Cl) increased with time and were evenly distributed throughout the 
entire cell in a CHX-treated sensitive strain. CHX-resistant isolates were less electron-dense and the chlorine signal 
increased with time from 30 to 60 min. Similarly, time-of-flight secondary-ion mass-spectrometry (TOF-SIMS) 
analysis was also able to distinguish between living and dead cells of Candida albicans biofilms that were treated 
with chlorhexidine digluconate (Tyler et al., 2006).  The dead cells did not contain high levels of intracellular 
potassium when compared to the living ones, indicative of a disrupted membrane. Furthermore, the chlorhexidine 
digluconate intensity in the dead cells was found to be higher than that in the surrounding medium, indicating that 
chlorhexidine digluconate bound preferentially to cellular components of the C. albicans biofilms. Transmission 
electron microscopic images of P. aeruginosa cells treated with 10 µg ml-1 CHX also revealed two cell types that 
correlated with a sensitive and a surviving cell type (Richards and Cavill, 1979) based on the appearance of the cell 
envelope.  
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In the present study, EDTA was shown to promote bioaccumulation of CHX in CHX-tolerant biofilms, as 
CHX was mapped in all of the EDTA-treated biofilm cells (wherein all cells were of the dark morphotype), which 
was not the case observed when the biofilms were treated with CHX alone. This further strengthens our CLSM 
findings that the bacterial membrane plays a key role in Delftia CHX tolerance. EDTA is well known to have a 
significant effect on the outer membrane permeability of Gram-negative bacteria (Lieve, 1974).  
IR spectroscopy has been used to evaluate the bulk chemical changes taking place within microbial 
biofilms (Holman et al., 2009; Quiles et al., 2010). In our study, the results from IR spectroscopic analysis were in 
agreement with our STXM results, as the diagnostic IR CHX-peak at 1492 cm-1 was seen in all CHX-treated 
biofilms, but more prominently in the MT51 biofilm, particularly at high CHX concentrations (Quiles et al., 2010). 
This is consistent with the observed increased accumulation of CHX in CHX-sensitive MT51 cells detected with 
STXM.  Since these peaks were highly-comparable with the CHX standard, we may further conclude that CHX 
does not appear to be modified or degraded within D. acidovorans biofilms. CHX degradation studies previously 
conducted in our laboratory using 14C-radiolabelled CHX and liquid scintillation spectrometry demonstrated that 
D. acidovorans (WT15) cannot mineralize CHX (data not shown), though CHX degradation by several other 
bacterial species is known (Tanaka et al., 2005). 
 
3.5.1. Conclusions 
CHX is a clinically useful and important antibacterial agent; however, some Gram-negative bacteria appear 
to be highly-resistant to CHX by a mechanism that, as yet, is not fully understood. Delftia acidovorans biofilms 
provided an ideal model system for integrating analysis of CLSM, STXM and IR data to gain insights into bacterial 
interactions with CHX at the micro- to nano-scales of resolution. While there were differences in the growth 
responses of biofilms exposed to CHX, it was significant that the biofilm mode of growth elevated the tolerance 
levels (compared to the planktonic MIC values) of both CHX-tolerant and CHX-sensitive strains of D. 
acidovorans.  It thus appeared that even long-term exposure to CHX was not sufficient to completely eradicate D. 
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acidovorans biofilms of either strain.  STXM allowed quantitative and high resolution (~30 nm) in situ mapping of 
the spatial distribution of CHX in cells and revealed differential uptake of CHX in WT15 and MT51 D. 
acidovorans. Disruption of the membrane protein TolQ gene, along with differential intake of CHX by these strains 
and increase intake of CHX in presence of the membrane permeabilising agent, EDTA, indicates the potential role 
of the cell membrane in CHX resistance. Although the microscopy/spectroscopy techniques used in this study can 
be employed as useful tools in studying these phenomena, more detailed molecular characterization of the role of 
TolQ gene in CHX resistance in these strains will further provide insights into the actual mechanism of CHX 
resistance. 
 
3.6. Connection to next study 
Study 1 demonstrated the differences between the CHX-tolerant and CHX-susceptible strains of D. 
acidovorans biofilms exposed to CHX using microscopic techniques, and suggested a possible role of the cell 
membrane and TolQ in CHX tolerance. The following study was undertaken to further understand the molecular 
mechanisms of CHX tolerance in these strains primarily by employing a well-known proteomic technique (DIGE). 
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4. PROTEOMIC ANALYSES OF CHLORHEXIDINE TOLERANCE MECHANISMS IN DELFTIA 
ACIDOVORANS BIOFILMS 
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4.1. Abstract 
Protein expression and fatty acid profiles of biofilm cells of chlorhexidine-tolerant Delftia acidovorans 
(MIC = 15 µg ml-1) and its chlorhexidine-susceptible mutant (MIC = 1 µg ml-1) were investigated. The 
chlorhexidine-susceptible mutant (MT51) was derived from the parental strain (WT15) using Tn5 transposon 
mutagenesis. The disrupted gene was identified as tolQ, a component of the TolQRAB gene cluster, known to be 
involved in outer membrane stability. Proteomic responses of biofilm cells were compared by differential in-gel 
electrophoresis following exposure to chlorhexidine at sub-MIC (10 µg ml-1) and above-MIC (30 µg ml-1) 
concentrations. Numerous changes in protein abundance were observed in biofilm cells following chlorhexidine 
exposure, suggesting that molecular changes occurred during adaptation to chlorhexidine. Forty proteins showing 
significant differences (fold change ≥ 1.5, P <0.05) were identified by mass spectrometry and were associated with 
various functions, including amino acid and lipid biosynthesis, protein translation, energy metabolism and stress-
related functions (e.g. GroEL, aspartyl/glutamyl-tRNA amidotransferase, elongation factor Tu, Clp protease, 
hydroxymyristoyl-ACP dehydratase). Several proteins involved in fatty acid synthesis were affected by 
chlorhexidine, in agreement with fatty acid analysis, wherein chlorhexidine-induced shifts in the fatty acid profile 
were observed in the chlorhexidine-tolerant cells, primarily the cyclic fatty acids. Transmission electron 
microscopy revealed more prominent changes in the cell envelope of chlorhexidine-susceptible MT51 cells. This 
study suggests that multiple mechanisms involving both the cell envelope (and likely TolQ) and pan-metabolic 
regulation play roles in chlorhexidine tolerance in D. acidovorans. 
 
4.2. Importance 
Delftia acidovorans has been associated with a number of serious infections, including bacteremia, 
empyema, bacterial endocarditis, and ocular and urinary tract infections.  It has also been linked with a variety of 
surface-associated nosocomial infections. Biofilm-forming antimicrobial resistant D. acidovorans strains have also 
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been isolated, including ones displaying resistance to the common broad spectrum agent, chlorhexidine. The 
mechanisms of chlorhexidine resistance in D. acidovorans are not known; hence, a chlorhexidine-susceptible 
mutant of the tolerant wild type strain was obtained using transposon mutagenesis, and the proteome and 
ultrastructural changes of both strains were compared under chlorhexidine challenge.  
 
4.3. Introduction 
Chlorhexidine is a broad-spectrum antimicrobial agent with wide application as an active ingredient in 
many daily-use disinfectants, pharmaceutical, personal and healthcare products (Ranganathan, 1996). Though 
chlorhexidine is often referred to as a “gold-standard” agent (Jones, 1997; Moshrefi, 2002) by health professionals, 
owing to its antibacterial efficacy, there are several reports of microorganisms surviving in the presence of in-use 
chlorhexidine concentrations (Marrie and Costerton, 1991; Stickler et al., 1987; Brooks et al., 2002). However, 
very little is known of the underlying mechanisms for this tolerance. Chlorhexidine tolerance compared to their 
planktonic counterparts (Hoiby et al., 2010). Antimicrobial resistance mechanisms in biofilm bacteria have been 
well-studied (Hoiby et al., 2010; Lewis, 2001; Mah and Toole, 2001). However, there remains a dearth of 
understanding of the mechanisms involved in chlorhexidine resistance in microbial biofilms. The elucidation of the 
molecular details of antimicrobial resistance continues to be an active and valuable area of research. The few 
molecular studies conducted to date on chlorhexidine resistance have mainly relied upon genomic approaches 
(Fang et al., 2002; Wang et al., 2008; Coenye et al., 2011). However, proteomic analysis has also proven valuable 
for antimicrobial resistance studies involving a variety of agents (Mangalapalli-Illathu and Korber, 2006; Weber et 
al., 2008; Pinto et al., 2010; Cagas et al., 2011). An important distinction between genomic and proteomic 
approaches is that only expressed genes yielding functional proteins are detected. 
Gel-to-gel variability is a major drawback of gel-based techniques, leading to problems in detecting and 
quantifying differences in protein expression (Asirvatham et al., 2002). Ünlü et al., (1997) developed an approach 
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involving the multiplexing of fluorescently-labeled samples on the same gel; two-dimensional difference in-gel 
electrophoresis (DIGE). DIGE involves pre-labelling of different protein samples with spectrally-resolvable 
fluorescent dyes that are charge- and mass-matched, ensuring an equivalent impact on in-gel migration of labelled 
proteins and improving the overall accuracy of relative quantification between samples (Karp et al., 2004).  
Delftia acidovorans is a Gram negative bacterium ubiquitously found in soil and water and associated with 
a number of serious infections, including: bacteremia, empyema, bacterial endocarditis, and ocular and urinary 
tract infections (del Mar Ojeda-Vargas et al., 1999; Cho and Lee, 2002; Perla and Knutson, 2005). Delftia 
acidovorans has also been implicated in various nosocomial biofilm infections associated with the use of medical 
devices like vascular catheters (Ender et al., 1996; Kawamura et al., 2011), pressure-monitoring devices 
(Weinstein et al., 1996) and surgical instruments (Mino de Kaspar et al., 2000). Relatively little is known about D. 
acidovorans’ pathogenicity, prevalence, health and environmental risks, genetic information, antibiotic resistance 
profile and stress response mechanisms. Clinical D. acidovorans strains have shown resistance to β-lactams and 
related antibiotics such as aminoglycosides and quinolones (Ravaoarinoro and Therrien, 1999, Kam et al., 2012). A 
strain resistant to chlorine was found in contaminated dental water units (Stampi et al., 1999). More recently, 
Delftia spp. were shown to carry class 3 integrons, the genetic elements commonly-associated with antibiotic 
resistance genes (Xu et al., 2007), indicating that this organism may horizontally-acquire resistance genes from 
microbes in the environment. 
A chlorhexidine-tolerant D. acidovorans strain (WT15) (MIC = 15 µg ml-1) was isolated from a river 
biofilm and characterized (Rema et al., 2014). A chlorhexidine-susceptible mutant (MT51) (MIC = 1 µg ml-1) was 
derived from WT15 using Tn5 transposon mutagenesis (Rema et al., 2014). We then used whole-proteome analysis 
of chlorhexidine-tolerant and chlorhexidine-susceptible D. acidovorans biofilms grown in the presence and 
absence of chlorhexidine in order to examine the adaptive response.  
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4.4. Materials and methods 
4.4.1. Bacteria, culture conditions and MIC determination 
A chlorhexidine-tolerant strain (WT15) of D. acidovorans (MIC = 15 µg ml-1) was isolated and 
characterized from South Saskatchewan River water biofilms (Rema et al., 2014). Resistance to biocides is often 
referred to as tolerance (Rema et al., 2014). Based on comparison of the chlorhexidine MIC value for WT15 D. 
acidovorans (15 µg ml-1) with MIC values from other reported studies, WT15 can be considered as being 
“tolerant” to chlorhexidine.  The chlorhexidine-susceptible mutant (MT51) (MIC = 1 µg ml-1) was created from 
WT15 using Tn5 transposon mutagenesis and previously characterized in detail (Rema et al., 2014). For biofilm 
cultivation purposes, the wild-type and mutant strains were grown from frozen stock cultures that were stored in 
10% (vol/vol) glycerol at −80°C on full strength tryptic soy agar (TSA) plates, and incubated overnight at room 
temperature (22 ± 2°C). Well-isolated colonies were then grown in 1% strength TSB till mid-log phase (optical 
density of 0.4 at 600 nm) and subsequently used to inoculate the flow cells set up for the study.  
Delftia acidovorans strains were screened for antibiotic resistance by using Sensititre CMV1AGNF plates 
(TREK Diagnostic Systems, Thermo Scientific, Waltham, Massachusetts) and the microdilution method of 
Andrews (2001). The plates contained 17 antimicrobial agents dosed in 96 wells at appropriate 2-fold dilutions 
(i.e., 64, 32, 16, 8, 4, 2,1, 0.5, 0.25, 0.12 µg ml-1) following the National Antimicrobial Resistance Monitoring 
System of the Centers for Disease Control.  Each well of the microtiter plate was inoculated according to 
manufacturer’s instructions, followed by room temperature incubation for 24 h. MIC’s were manually determined 
for each isolate as the lowest concentration of each antibiotic that inhibited visible growth. MIC values for 
chlorhexidine were conducted using the same microdilution scheme. Subsequently, a finer set of chlorhexidine 
concentrations were used (i.e., 9, 10, 11, 12, 13, 14, and 15 µg ml-1).  The MIC breakpoints were determined 
according to the Clinical and Laboratory Standards (formerly the National Committee for Clinical Laboratory 
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Standards) M100 (NCCLS, 2002) and M31 (NCCLS, 2002a) standards. 
 
4.4.2. Identification of transposon insertion site 
The gene interrupted by transposon (Tn5) insertion in D. acidovorans (MT51) was identified by the rapid 
amplification of transposon ends (RATE) technique, as described by Karlyshev et al. (2000). Amplified products 
were analysed by electrophoresis on a 1% agarose gel in 1X TAE buffer containing 0.5 µg ml-1 ethidium bromide. 
The product band was purified using the QIAquick Gel Purification kit (Qiagen, Mississauga, ON) as per the 
manufacturer’s instructions and then sent to the National Research Council of Canada, Saskatoon, Saskatchewan, 
Canada for sequencing. The sequence of the disrupted gene (tolQ) from WT15 was then compared with sequences 
published in the NCBI Nucleotide Database. The sequence data for TolQ was submitted to the GenBank database 
under accession number KT988307. TolQ has been shown to be an integral cytoplasmic membrane protein 
required for maintenance of the integrity of the bacterial envelope in E. coli (Vianney et al., 1994).  
 
4.4.3. Cultivation of biofilms  
Wild type and mutant biofilms were cultivated in multichannel flow cells, as explained in Rema et al. 
(2014). To evaluate the effect of chlorhexidine, established (24 h) biofilms were treated for another 24 h period 
with sterile medium supplemented with either sub-MIC (10 µg ml-1) or above-MIC level (30 µg ml-1) chlorhexidine 
concentrations. Biofilms that were not exposed to chlorhexidine and grown under similar conditions for a period of 
48 h served as controls.  
 
4.4.4. Transmission Electron Microscopy (TEM) 
Biofilm cells were aseptically scraped from flow cells and the material transferred directly to sterile 
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microcentrifuge tubes. The tubes were couriered on ice to the Electron Microscope Facility, McMaster University, 
ON, where further processing of the samples was immediately performed, as per the procedure followed by 
Lawrence et al. (2003) with a few modifications. Ultra-thin sections were cut with a diamond knife mounted on a 
Leica UCT Ultramicrotome and placed on TEM grids (Marivac Canada, Canton de Gore, PQ). Lastly, sample thin-
sections were post-stained with uranyl acetate, followed by Reynold's lead-citrate staining and then viewed on a 
JEOL JEM 1200 EX TEMSCAN transmission electron microscope (JEOL, Peabody, MA). 
 
4.4.5. Cellular fatty acid analysis  
To determine whether chlorhexidine treatment influenced fatty acid composition of the cells, the following 
analysis was conducted.  Biofilms were cultivated in the presence and absence of chlorhexidine (10 µg ml-1) as 
described above. Biofilm cells were then scraped from the flow cell and collected in a 15 ml centrifuge tube 
followed by centrifugation at 4,000 rpm for 10 min. Total fatty acids were extracted from 40 to 50 mg (wet weight) 
of cell pellet and methyl-esterified as described by Annous et al. (1997). A Hewlett Packard 5890 series 2 gas-
liquid chromatograph (Hewlett Packard, Avondale, PA) equipped with a flame ionization detector and a capillary 
column (Ultra 2; Hewlett Packard catalog no. 19091B-102; cross-linked 5% phenyl-methyl silicone; 25 m by 0.22 
mm [inside diameter]; film thickness, 0.33 mm; phase ratio, 150) with hydrogen as the carrier gas was used for 
separation and detection of fatty acid methyl esters (FAMEs). The FAME peaks were automatically integrated by 
Hewlett Packard 3365 ChemStation software, and individual fatty acids were identified with the MIDI Microbial 
Identification Software (Sherlock TSBA Library version 3.80; Microbial ID, Inc., Newark, DE). 
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4.4.6. DIGE analysis of total cellular proteins 
4.4.6.1. Experimental design, sample preparation and Cy-Dye Labeling   
Control and chlorhexidine-treated MT51 and WT15 biofilms grown for 48 h under flowing conditions were 
aseptically recovered for extraction of protein, as previously described (Mangalapalli-Illathu et al., 2008). In total, 
there were six biofilm treatment groups (WT15 control designated as WC, MT51 control (MC), WT15 treated at 
10 µg ml-1 chlorhexidine (W10), WT15 treated at 30 µg ml-1 chlorhexidine (W30), MT51 treated at 10 µg ml-1 
chlorhexidine (M10) and MT51 treated at 30 µg ml-1 chlorhexidine (M30)) with three biological replicates for each 
group, prepared independently from separate experiments. Sample preparation for DIGE analysis, which included 
cell lysis, protein extraction and solubilisation, was carried out as detailed previously (Sampathkumar et al., 2004). 
The dye-binding assay of Bradford (1976) was then performed to quantify the extracted cellular proteins by using a 
protein assay kit (Bio-Rad Laboratories, Hercules, CA). The extracted protein was further precipitated using the 2D 
clean-up kit (GE Healthcare, Mississauga, ON) as per the supplier’s protocol and resuspended in cell lysis buffer (7 
M urea, 2 M thiourea, 4 % w/v CHAPS, 30 mM TrisCl, pH 9.0) to a final concentration of 5 µg/µl. The pH of the 
protein samples was adjusted to 8 and a total of 50 µg protein per sample was used for labelling reactions. The 
pooled internal standard was prepared by mixing equal amounts of protein from all treatments, and dispensing them 
in 50 µg aliquots prior to labeling.  
Protein samples were labeled using fluorescent cyanine dyes (GE Healthcare) in accordance with the 
manufacturer’s protocols. Cyanine dyes (Cy3 and Cy5) were freshly reconstituted in dimethylformamide and added 
to the labeling reactions at a ratio of 400 pmol dye to 50 µg protein.  Labeling reactions were performed in the dark 
for 30 min and on ice, after which the reactions were terminated by the addition of 10 mM lysine (1 µl per 400 
pmol dye).  Each of the three replicates within a group was labeled with Cy3, Cy5 and Cy3 or Cy5. The pooled 
internal standard was labeled with Cy2 fluorescent dye. Sample multiplexing was also randomized to produce 
unbiased results. 
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4.4.6.2. Two-dimensional gel electrophoresis (2D-GE) 
For every gel, 50 µg each of Cy3-labelled and Cy5-labelled protein samples were mixed with the Cy2-
labelled pooled standard and added to rehydration buffer (7 M urea, 2 M thiourea, 2 % w/v CHAPS, 13 mM 
dithiothreitol (DTT), 0.5 % IPG buffer 4–7) to a total volume of 450 µl and loaded onto 24 cm, pH 4–7 IPG strips 
(GE Healthcare) and left overnight for rehydration. Isoelectric focusing (IEF) was performed using an Ettan 
IPGphor 3 (GE Healthcare) apparatus for a total of 57500 Vh at 75 µA and 20°C. The focused IPG strips were first 
equilibrated for 15 min with freshly added DTT (0.5% w/v) and then with iodoacetamide (4.5% w/v) for another 
15 min in equilibration buffer (50 mM TrisCl (pH 8.8), 6 M urea, 30% glycerol, 2% w/v SDS and 0.02% 
bromophenol blue). Second-dimension electrophoresis was performed on 12.5% polyacrylamide gels using the 
Ettan DALT Six apparatus (GE Healthcare). Gels were run at 1 W per gel for 1 h, and at 17 W per gel at 20°C until 
the bromophenol blue tracking front had just run off the bottom of the gels.  
 
4.4.6.3. Image acquisition and data analysis 
Cy2, Cy3, and Cy5 images for each gel were scanned at 488/520-, 532/580-, and 633/670-nm 
excitation/emission wavelengths, respectively, at 100 µm resolution using a Typhoon FLA9000 scanner (GE 
Healthcare). The images were then cropped using ImageQuant v5.0 and processed using DeCyder v7.0 differential 
analysis software (GE Healthcare), as per the manufacturer’s protocol. The differential in-gel analysis module of 
DeCyder software was used for spot co-detection and quantitation. The biological variation analysis (BVA) 
module was used for inter-gel matching of internal standard and samples across all gels and allowed quantitative 
comparisons of protein expression across all gels.  ANOVA and Student’s t tests were performed between different 
treatment groups. The Extended Data Analysis (EDA) module of the DeCyder software was also used for 
multivariate analysis of protein expression data after which Principal Component Analysis (PCA) was performed 
to find experimental outliers and patterns in expression data. DIGE data was exported and compared by principal 
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component analysis (PCA) with PRIMER v6 software. Statistical analyses of PCA scores generated from the first 
two component axes were run using an analysis of similarity (ANOSIM) with PRIMER v6 software (PrimerE-Ltd 
Lutton, UK). The following criteria was used to select proteins of interest: a) spots that showed a significant 
change in expression (P <0.01 and fold difference of more than 1.5, b) spots present in all gel images, and c) spots 
that gave a q score of more than 70 in cluster analysis.  Finally, matches and data quality of proteins of interest 
were manually checked to avoid false positives.  Forty-five spots were then marked as spots of interest to be picked 
for identification using mass spectrometry.   
 
4.4.6.4. Protein identification 
After second dimension electrophoresis, the pick gels were stained with Deep Purple fluorescent dye 
following the supplier’s protocol (GE Healthcare). The gels were scanned in a Typhoon FLA9000 scanner at 100 
µm resolution using the 532/LP 560 emission/excitation wavelengths. The preparative and analytical images were 
matched using the BVA module of the DeCyder software. Reference markers and spot picking locations were 
designated and edited as required. The pick list was then exported to the Ettan Spot picker (GE Healthcare) where 
the protein spots of interest were excised from the gel following the manufacturer`s protocol. The excised spot 
plugs were transferred to a 96-well microtitre plate, destained and digested using trypsin in the MassPrep II 
Proteomics Workstation (Micromass, UK) as per the method described by Sheoran et al. (2005). The proteins were 
then identified by liquid chromatography nano-electrospray ionization mass spectrometry (LC-ESI-MS). For LC-
ESI-MS analysis, a Quadrupole Time-Of-Flight (Q-TOF) Global Ultima mass spectrometer (Micromass, 
Manchester, UK) equipped with a nano-electrospray (ESI) source and interfaced with a nanoACQUITY UPLC 
solvent delivery system (Waters, Milford, MA, USA) was used. The data generated from LC-ESI-MS was 
processed with the ProteinLynx Global Server 2.4 (PLGS 2.4, Waters) and subsequently submitted to Mascot 
(Matrix Science Ltd., London, UK) for peptide searching against the National Center for Biotechnology 
Information protein database. Gene ontology (GO) enrichment analysis was conducted using the Database for 
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Annotation, Visualization and Integrated Discovery (DAVID) to identify the biological processes and molecular 
functions of the proteins thus identified (Huang et al., 2009). 
 
4.5. Results  
4.5.1. Identification of transposon insertion site and antimicrobial resistance patterns 
To elucidate the molecular mechanism of chlorhexidine tolerance in D. acidovorans, we carried out 
transposon mutagenesis (Rema et al., 2014) to create a chlorhexidine-susceptible mutant strain (MT51). The MIC 
of strain MT51 (1 µg ml-1) for chlorhexidine was fifteen times lower than the parent strain WT15 (MIC-15 µg ml-
1). Identification of the DNA sequence flanking the transposon insertion site in this mutant revealed that the 
transposon was inserted into the 81st bp of the 705-bp DNA region encoding the protein, TolQ. The sequence 
identity of this gene matched 100% to D. acidovorans SPH1 strain tolQ sequence published in the Nucleotide 
Database, National Center for Biotechnology Information (NCBI). Several attempts to create a complementation 
mutant to study the polar affects of tolQ mutation failed and consequently could not be examined in this thesis. 
Apart from chlorhexidine susceptibility, transposon mutation also rendered the MT51 strain less resistant to 
amikacin (MIC values of 16 and 64 µg ml-1 for MT51 and WT15, respectively) among the 17 antibiotics in the 
National Antimicrobial Resistance Monitoring System of the Centers for Disease Control panel (Table 4.1). MIC 
values for the other 16 antimicrobial agents in the screened panel were not observed to change appreciably 
following mutagenesis.
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Table 4.1. Results of antibiotic and chlorhexidine susceptibility testing for D. acidovorans strains MT15 and 
WT51.   
  
Antibiotic 
MIC (µg ml-1) 
Wild type Mutant 
Amikacin* 64 16 
Chloramphenicol 16 16 
Cefoxitin <0.5 <0.5 
Tetracycline <4.0 <4.0 
Ceftriaxone* <0.25 0.5 
Amoxycillin 1 1 
Clavulanic acid 0.5 0.5 
Ciprofloxacin* 0.25 0.12 
Gentamicin 16 16 
Nalidixic acid 0.5 0.5 
Ceftiofur 0.5 0.5 
Sulfisoxazole 32 32 
Trimethoprim 0.12 0.12 
Sulfamethoxazole 2.38 2.38 
Kanamycin 64 64 
Ampicillin 32 32 
Streptomycin 64 64 
Chlorhexidine* 15 1 
MIC – minimum inhibitory concentration, * - indicates compounds for which differences in MIC were observed.
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4.5.2. Transmission Electron Microscopy (TEM)  
TEM was used to study the ultrastructural effects of chlorhexidine in both chlorhexidine-tolerant and 
chlorhexidine-susceptible D. acidovorans biofilm cells. Figures 4.1A and 4.1B are electron micrographs of cells 
recovered from 48 h untreated control WT15 and MT51 biofilms, respectively, and thus lack apparent damage to 
the cell envelop or coagulation of the cytoplasm. The WT15 biofilm cells treated at 10 µg ml-1 (Fig. 4.1C) appear 
similar to the WT15 untreated cells; however, the 10 µg ml-1 chlorhexidine treatment produced an effect on MT51, 
especially at the cell envelope where membrane bulging and detachment of cell membrane from the cell wall was 
observed (see arrows in Fig. 4.1D). Similar membrane waviness and damage was apparent in both MT51 and 
WT15 biofilms treated with 30 µg ml-1 chlorhexidine (Fig. 4.1F), suggesting that a lethal dose of chlorhexidine 
exerts membrane-level effects on D. acidovorans cells. 
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Fig. 4.1. TEM micrographs of 48 h D. acidovorans biofilm cells with and without exposure to 10 and 30 µg ml-1 
chlorhexidine after 24 h of growth. A-WT15 Control; B-MT51 Control; C-WT15 treated with chlorhexidine at 10 
µg ml-1; D-MT51 treated with chlorhexidine at 10 µg ml-1; E-WT15 treated with chlorhexidine at 30 µg ml-1; F- 
MT51 treated with chlorhexidine at 30 µg ml-1. Arrowheads show membrane structural alterations. Scale bar = 500 
nm. 
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4.5.3. Cellular fatty acid analysis  
Treated (10 µg ml-1 chlorhexidine) and untreated biofilms of chlorhexidine-tolerant WT15 and 
chlorhexidine-susceptible MT51 biofilms were subjected to fatty acid methyl ester (FAME) analysis. The fatty 
acids detected in WT15 control biofilms after 48 h of growth (Fig. 4.2) included both saturated fatty acids (12:0 
and 16:0) and unsaturated fatty acids (16:1ω7c/15 iso2OH, 17:1ω5c, and 18:1ω7c). Treatment of chlorhexidine-
tolerant WT15 biofilms with 10 µg ml-1 chlorhexidine resulted in a reduction in the concentration of total 
unsaturated fatty acids from an initial value of 68.2% to 63.6% (Fig. 4.2), apparently due to the disappearance of 
17:1ω5c fatty acid. Simultaneously, there was a minor increase in saturated fatty acids and the appearance of a new 
group, the cyclic fatty acids (17:0 cyclo), in the chlorhexidine-treated wild type biofilms. The unsaturated fatty 
acid, 17:1 5c, was not found in mutant MT51 biofilms. When MT51 biofilms were exposed to chlorhexidine (10 
µg ml-1), the level of unsaturated fatty acids increased slightly from 68.4% to 70.1%, and no production of cyclic 
fatty acids was observed. 
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Fig. 4.2. Relative amounts (%) of fatty acid methyl esters, determined using gas chromatography, found in 
chlorhexidine-tolerant (WT15) and chlorhexidine-susceptible (MT51) D.  acidovorans biofilm cells treated with 
(10 µg ml-1 with chlorhexidine) compared with the untreated control. CFA- cyclo fatty acids, UFA – unsaturated 
fatty acids, SFA – saturated fatty acids. 
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4.5.4. Proteomic analyses 
DIGE analyses were carried out using: 1) 48 h WT15 and MT51 control biofilms receiving no 
chlorhexidine, and 2) WT15 and MT51 biofilms treated for 24 h with 10 and 30 µg ml-1 chlorhexidine after 24 h of 
initial biofilm growth. Principal Component Analysis (PCA) was used to group the 18 individual Cy3- or Cy5-
labeled spot maps based on the overall expression pattern of all 999 spots matched between gels, and to identify 
any experimental outliers. The PCA of spot maps (Fig. 4.3) demonstrated a high reproducibility between replicate 
samples, as indicated by close grouping of the experimental replicates. The first principal component accounted for 
43.7% of total variance and clearly separated the MT51 control, MT51 treated (10 µg ml-1) and WT15 control 
groups from each other and indicated little separation between the WT15 control and WT15 treated biofilms. 
However, the second principal component, which accounted for 17% of the variance, differentiated WT15-treated 
groups from the other experimental groups. PCA results indicated significant differences between mutant and wild 
type control biofilms (ANOSIM, p<0.001). Mutant treated biofilms tended to group together (ANOSIM, p<0.001) 
indicating similar proteomic response. Overall, PCA demonstrated that both strains were differentially-affected by 
chlorhexidine treatment relative to their untreated controls.  
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Fig. 4.3. Principal Component Analysis of the 18 individual DIGE expression spot maps (6 treatments with three 
replications per treatment) differentiated by principle components one and two. Statistical analyses of PCA scores 
generated from the first two component axes were run using an analysis of similarity (ANOSIM) with PRIMER v6 
software. M10, M30 - mutant strain treated with 10 and 30 µg ml-1 chlorhexidine, respectively; W10 and W30 – 
wild type strain treated with 10 and 30 µg ml-1 chlorhexidine, respectively; MC and WC –mutant and wild type 
controls respectively. 
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DIGE analysis revealed numerous protein species-abundance changes in both wild type and mutant 
biofilms when exposed to sub-MIC (10 µg ml-1) and above-MIC (30 µg ml-1) chlorhexidine levels. The number of 
differentially expressed proteins among various groups compared is shown in Table 4.2. For example, 114 proteins 
were differentially expressed between untreated control WT15 and MT51 biofilms, of which 70 were up regulated 
and 44 were down-regulated in MT51. Table 4.2 also shows that the number of differentially-expressed proteins 
with respect to the two chlorhexidine concentrations was 9 (5 were up-regulated and 4 were down-regulated) in 
WT15 biofilms; whereas, 56 proteins (30 were up-regulated and 26 were down-regulated) were differentially-
expressed in MT51 biofilms. This finding is in keeping with our TEM data (Fig. 4.1) that showed that MT51 was 
more dramatically affected by chlorhexidine treatment.  Two-way ANOVA analysis showed that treatment-specific 
differential expression of proteins was more profound than the effect of the tolQ mutation (P< 0.05), as 106 
proteins were differentially-expressed (among the mutant and wild type) across all treatments; whereas, only 60 
proteins were affected due to transposon insertion. A further breakdown of the differential protein abundance 
according to fold-change, is shown in Figure 4.4. Chlorhexidine treatment induced higher fold-changes (>1.5) in 
both WT15 and MT51 biofilms compared to differences in protein expression between the respective untreated 
controls. However, the protein expression changes in the same biofilm treated with 30 µg ml-1 chlorhexidine were 
comparatively higher in MT51 than the WT15 biofilms relative to their respective biofilms exposed to 10 µg ml-1. 
Only one spot each showed increased and decreased abundance of 2- to 3-fold in wild type biofilms treated with 
high versus low concentrations of chlorhexidine; 
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whereas, 2 spots with increased, and 7 spots with decreased, abundance of 2- to 3-fold were seen in mutant 
biofilms.  
Out of 45 differentially-expressed proteins picked, 40 proteins were successfully identified and are 
summarized in Table 4.3, along with their molecular functions, accession numbers and abundance fold-changes. 
Based on their known functions and Database for Annotation, Visualization and Integrated Discovery (DAVID) 
analysis, these identified proteins were broadly categorised as those involved in amino acid and lipid biosynthesis, 
translation/transcription, energy metabolism, membrane and stress-related functions. DAVID analysis (Fig. 4.5) 
shows the major biological and molecular processes that were affected due to chlorhexidine treatment in WT15 and 
MT51 biofilms. The most pronounced changes observed were the down-regulation of proteins involved in 
biological processes, as listed in Figure 4.5. Of the forty identified proteins, 12 proteins increased in abundance in 
both strains (WT15 and MT51) at both concentrations of chlorhexidine. These included chaperonin GroEL, 
aspartyl/glutamyl-tRNA amidotransferase subunit A, F0F1 ATP synthase subunit alpha, elongation factors Tu and 
Ts, phosphopyruvate hydratase, amidohydrolase, basic membrane lipoprotein, electron transfer flavoprotein and 
ATP-dependent Clp protease. Those that were decreased in abundance in both WT15 and MT51 biofilms included 
ribosomal subunit interface protein, AMP-binding domain-containing protein and a hypothetical protein (ferritin-
like superfamily). The chaperonin protein, ClpP (spot no. 658, Table 4.3), was found to be up-regulated in WT15 
biofilms exposed to the inhibitory (30 µg ml-1) chlorhexidine concentration and was higher and almost similar in 
both 10 µg ml-1 and 30 µg ml-1 treated MT51 biofilms, suggesting that both these 
 
  
93 
 
Fi
g.
 4
.5
. G
en
e 
on
to
lo
gy
 c
lu
st
er
 (D
A
V
ID
) a
na
ly
si
s 
of
 p
ro
te
in
s 
up
-r
eg
ul
at
ed
 (b
lu
e)
 a
nd
 d
ow
n-
re
gu
la
te
d 
(r
ed
) i
n 
W
T1
5 
an
d 
M
T5
1 
bi
of
ilm
s 
tre
at
ed
 w
ith
 
ch
lo
rh
ex
id
in
e 
at
 1
0 
an
d 
30
 µ
g 
m
l-1
 s
ho
w
in
g 
th
e 
bi
ol
og
ic
al
, m
ol
ec
ul
ar
 a
nd
 c
el
lu
la
r p
ro
ce
ss
es
 th
at
 w
er
e 
af
fe
ct
ed
. T
he
 p
ro
te
in
s 
w
er
e 
pi
ck
ed
 fr
om
 th
e 
de
ep
 
pu
rp
le
-s
ta
in
ed
 p
ic
k 
ge
l a
nd
 a
na
ly
ze
d 
by
 m
as
s s
pe
ct
ro
m
et
ry
.  
 
 94 
chlorhexidine concentrations were stressful to MT51. Similarly, the chaperonin, GroEL, was also significantly up 
regulated in MT51 chlorhexidine-treated biofilms compared with WT15 chlorhexidine-treated biofilms. Several 
protein spots with slightly different electrophoretic migration patterns were determined to be the same protein (i.e., 
chaperonin GroEL, ATP synthase and elongation factor Tu), which may imply that charge or post-translational 
modifications had occurred (dos Santos et al., 2010).  Another protein, the small heat shock protein HSP 20 (spot 
no. 886, Table 4.3), which is an ATP-independent molecular chaperone, was also significantly down-regulated by 
nearly 7-fold only in wild type chlorhexidine-treated biofilms. There was also a more than 2-fold decrease in 
expression of phasin proteins (Table 4.3) in WT15 chlorhexidine-exposed biofilms compared to MT51 biofilms. 
Oxidative stress proteins, namely superoxide dismutase, hypothetical protein (alkylhydroperoxidase-like protein, 
AhpD family) and redoxin domain-containing protein, were found to be either down-regulated or showed no 
significant changes in WT15 and MT51 biofilms (Table 4.3).  
Consistent with our FAME results, several enzymes associated with fatty acid synthesis were also found to 
be affected by chlorhexidine treatment in both WT15 and MT51 biofilms.  They included malonyl CoA-acyl 
carrier protein transacylase (spot no. 478), enoyl-CoA hydratase/isomerase (spot no. 563) and (3R)-
hydroxymyristoyl-ACP dehydratase (spot no. 770).  A dramatic increase, from ~3.3- to 7.5-fold, in the expression 
of a basic membrane lipoprotein (spot no. 371, Table 4.3) in both WT15 and MT51 chlorhexidine-treated biofilms 
indicated that this protein may play a very important role in chlorhexidine tolerance in D. acidovorans. A role for 
quorum sensing is also suggested by the down-regulation of the two-component LuxR family transcriptional 
regulator (spot no. 629, Table 4.3), especially in WT15 biofilms treated with the high concentration of 
chlorhexidine.
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Chlorhexidine treatment also doubled the abundance of amidohydrolase enzyme in both WT15 and MT51 
biofilms (spot no. 218, Table 4.3). Similarly, proteins involved in protein synthesis, folding and stabilisation 
(GroEL, ClpP protease, aspartyl/glutamyl-tRNA amidotransferase, elongation factors Tu and Ts) and a few 
proteins associated with energy production, nucleotide transport and metabolism increased in abundance (i.e., 
bifunctional phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrolase, phosphopyruvate 
hydratase, F0F1 ATP synthase subunit alpha/beta and electron transfer flavoprotein). However, the enzyme 
glutamine amidotransferase (spot no. 606, Table 4.3), also involved in nucleotide transport and metabolism, 
decreased in abundance by almost 3.5 times in WT15 biofilms at both chlorhexidine concentrations; whereas, the 
taurine catabolism dioxygenase TauD/TfdA (spot no. 292) abundance increased more than two-fold in WT15 
biofilms treated with chlorhexidine.  
The major differences between the wild type and mutant control biofilms were the increase in abundance of 
the ATP synthases, a few enzymes involved in fatty acid metabolism, and hydroxyacylglutathione hydrolase and 
decrease in abundance of glutamine amidotransferase, several molecular chaperones and family phasin protein in 
mutant biofilms compared to their parent biofilms (Table 4.3).  
 
4.6. Discussion 
Mutation of tol genes has previously been shown to confer hypersensitivity to various agents, such as 
detergents, quaternary compounds, and some antibiotics in Escherichia coli (Dennis et al., 1996). However, little is 
known about TolQ’s functional role in D. acidovorans. In E. coli, TolQ is an integral cytoplasmic membrane 
protein (230 amino acids) with three membrane-spanning regions required for maintenance of the integrity of the 
bacterial envelope (Vianney et al., 1994). The tolQRAB-pal operon also functions in the uptake of certain 
bacteriophages and colicins and is conserved in Gram negative genomes (Dennis et al., 1996). Studies also suggest 
that the Tol/Pal system might anchor the OM to the peptidoglycan layer (Clavel et al., 1998) and further may 
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catalyse porin biogenesis or activity (Dover et al., 2000).  It was thus hypothesised that a mutation in tolQ in D. 
acidovorans would affect the cell envelope’s integrity upon exposure to chlorhexidine, a membrane-active agent 
(Hope and Wilson, 2004). Due to the absence of complete knowledge of TolQ in D. acidovorans, along with 
limitations in the present study and failed attempts for complementation studies, it is possible that TolQ influenced 
the activity of other proteins not detected in our DIGE analysis.  For example, Omp32, undetected in our analyses, 
has been found to have strong anion selectivity and can repulse the penetration of positively-charged compounds 
such as chlorhexidine (Zeth et al., 2000). Previously, we demonstrated that more chlorhexidine was found to 
accumulate inside chlorhexidine-susceptible MT51 cells than in chlorhexidine-tolerant cells (Rema et al., 2014), 
clearly pointing to selectivity in chlorhexidine penetration.  
TEM has seen extensive use to study the effects of antimicrobial agents on microorganisms (Sampathkumar 
et al., 2004; Vitkov et al., 2005). Our TEM analyses provided clear evidence that chlorhexidine has a disruptive 
effect on the D. acidovorans cell envelope, in agreement with previous reports for other bacteria (Richards and 
Cavill, 1979; Russell, 2003; Gilbert and Moore, 2005). These observations are also consistent with the tolQ 
mutation influencing membrane integrity of D. acidovorans cells, wherein the mutant cells appeared more 
susceptible to chlorhexidine than the wild type (Fig. 4.1). Tattawasart et al. (Tattawasart et al.,2000) observed that 
chlorhexidine-resistant Pseudomonas stutzeri cells were larger, had fibril-like structures on their outer surfaces, 
and the cell envelope was wavier and thicker than those of susceptible isolates. Time-dependent cellular damage 
(i.e., blebbing of the outer membrane, cytoplasmic swelling) was also been seen in the case of susceptible isolates 
when treated with chlorhexidine (Tattawasart et al., 2000). These authors also observed extensive cell lysis, likely 
the consequence of exposing the cells to a significantly-higher chlorhexidine concentration (100 µg ml-1) than 
employed in our study. The type of bacteria, planktonic versus biofilm, chlorhexidine concentration, and period of 
exposure all play important roles in inducing ultrastructural changes in microorganisms (Vitkov et al., 2005).  
Changes in cell fatty acid composition in the presence of chlorhexidine possibly reflect alterations in 
membrane fluidity and symmetry, and offer a potential mechanism of chlorhexidine tolerance in D. acidovorans. 
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There were some differences in the major fatty acids detected in our chlorhexidine-tolerant D. acidovorans (Fig. 
4.2) after 48 h treatment compared with the D. acidovorans of Wen et al. (1999). These differences were likely due 
to the combined effect of using biofilm (our study) versus planktonic cells, as well as differences in growth 
conditions. In our study, chlorhexidine treatment caused a reduction in total unsaturated fatty acids associated with 
the disappearance of the 17:1ω5c fatty acid, and the de novo appearance of 17:0 cyclo fatty acids in the wild type 
strain. Such a change in membrane fatty acid composition has been associated with decreased membrane fluidity 
(Annous et al., 1997; Brown et al., 1997). Abu-Elteen and Whittaker (1997) observed that the percentage of 
unsaturated fatty acids decreased while the ratios of C16:C18 increased in the presence of chlorhexidine in 
Candida albicans.  Chlorhexidine has also been observed to alter the cell-membrane lipid packing order and 
membrane fluidity in human epithelial cells (Audus et al., 1992). The fatty acid compositional modifications (Fig. 
4.2) that were seen in WT15 biofilms in response to chlorhexidine treatment were not evident in the mutant 
chlorhexidine-treated biofilm, and thus appear to be part of the D. acidovorans adaptive response.  
DIGE has previously been used to elucidate the proteomes of bacterial drug resistance (dos Santos et al., 
2010; Fernandez-Reyes et al.,2009; Poutanen et al., 2009).  Our study is the first to investigate chlorhexidine-
induced changes in the D. acidovorans proteome. PCA analysis of the DIGE gels (Fig. 4.3) indicated that the effect 
of chlorhexidine on MT51 biofilm protein expression was distinct from its effect on the WT15 biofilms, and that 
both chlorhexidine-treated biofilms were different from their respective control biofilm conditions. These 
differences appear due to the mutation in the tolQ gene in MT51, as TolQ has previously been shown to influence 
antimicrobial resistance and membrane integrity in other bacterial cells (Dennis et al., 1996; Vianney et al., 1994). 
PCA analyses also confirmed significant differences (ANOSIM, p<0.001) between WT15 and MT51 control 
biofilms due to tolQ mutation.  Since WT15 is chlorhexidine-tolerant (Rema et al., 2014) (Table 4.1), we did not 
expect a large difference between the control and chlorhexidine-treated proteomes, especially at the lower 
concentration. In contrast, both low and high chlorhexidine concentrations used in this study were above the MIC 
determined for MT51 cells and so MT51 treated biofilms were significantly different from MT51 control biofilms 
(ANOSIM, p<0.001). Hence, it was hypothesized that the MT51 biofilms would experience greater chlorhexidine-
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induced stress than the WT15 biofilms, and this would be reflected by their proteome response. Previously, 
microscopic analyses (Rema et al., 2014) also showed greater effects of chlorhexidine on MT51 biofilms. 
Accordingly, the first principal component (PC1) showed that a greater differential effect on protein expression did 
in fact result from application of the two chlorhexidine concentrations (10 and 30 µg ml-1) on MT51 biofilms.  
Bacterial stress response is a coordinated outcome of the expression of a variety of genes that alter various 
cellular processes (cell division, DNA metabolism, housekeeping, membrane composition, transport, etc.) and the 
number of genes involved are numerous (Renzone et al., 2005). Information on the proteome of bacterial species 
exposed to chlorhexidine, or those of chlorhexidine-resistant isolates, are limited. Recently, Coeyne et al. (2011) 
used microarray analysis to assess molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia 
biofilms, revealing that 15 min exposure of B. cenocepacia to 0.15 µg ml-1 chlorhexidine resulted in the up-
regulation of 469 (6.56% of the total) and down-regulation of 257 (3.59% of the total) protein-coding genes (fold-
change > 2; P < 0.05). Similarly, the analysis of DIGE gels in our study revealed numerous protein species-
abundance changes in both wild type and mutant biofilms when exposed to sub- and above-MIC levels of 
chlorhexidine (Table 4.2). A greater number of proteins were affected (Fig. 4.4) in chlorhexidine-treated mutant 
versus untreated control biofilms than the treated and untreated wild type biofilms, suggesting that the MT51 
mutant was more dramatically-affected by chlorhexidine exposure, in keeping with our TEM and other 
observations. Two-way ANOVA (P < 0.05) analysis (Table 4.3) showed that treatment-specific differential 
expression was profound when compared to strain, as the proteome response in MT51 cells was the integrated 
effect of the mutated genetic background as well as above-MIC chlorhexidine exposure.  
A wide range of key enzymes and proteins involved in various biological and molecular processes were 
affected by chlorhexidine, as shown by gene ontology analysis (Fig. 4.5). The DIGE proteomic data revealed that 
the differentially-expressed proteins in these various treatment groups fell into several functional groups, mainly 
those involved in energy, nucleotide, fatty acid and amino acid metabolism, protein translation and modification, 
DNA binding and transcription, cell membrane-related functions and other cellular processes such as detoxification 
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and stress response (Table 4.3). The cytoplasmic membrane would be the highest-probability target for biocide 
action for chlorhexidine, causing functional perturbation of the membrane (Denyer and Stewart, 1998). This 
implies that the target enzymes and proteins for biocide action would be mostly those related to structural integrity, 
transport mechanisms, energy coupling processes, respiratory chain function and those that are membrane-bound 
(Denyer and Stewart, 1998), and this was consistent with our observations (Table 4.3). The majority of B. 
cenocepacia biofilm protein-coding genes over-expressed when treated with chlorhexidine coded for periplasmic 
and exporter proteins or lipoproteins, efflux systems and those that were required for structure and function of the 
inner membrane, transport or binding, chemotaxis and motility (Coenye et al., 2011). The majority of down-
regulated protein-coding genes were involved in transport or binding, or regulatory functions. Similarly, treatment 
of Pseudomonas aeruginosa planktonic cells with 0.008 mM chlorhexidine for 10 and 60 min revealed that 
membrane transport, oxidative phosphorylation, and electron transport genes were down-regulated (Nde et al., 
2009). The oprH gene and MexCD-OprJ multidrug efflux pump were among the up-regulated proteins found to 
play a major role in chlorhexidine resistance in P. aeruginosa (Nde et al., 2009).  
In our study, several stress response-related proteins were found to be differentially-expressed in the 
presence of chlorhexidine, including GroEL and ATP synthase. Other authors have made similar observations in 
organisms under antimicrobial stress (Poutanen et al., 2009; Cardoso et al., 2010; Karatzas et al., 2008). 
Overexpression of GroEL in MT51 biofilms may be directly related to the sensitivity of this strain to chlorhexidine 
and their stressed metabolic state. It further indicates that there may be an increased concentration of misfolded 
proteins in MT51 biofilms and chlorhexidine may interfere with protein synthesis or structure (Cardoso et al., 
2010). Similarly, there is evidence for the role of housekeeping genes, such as glutamyl-tRNA amidotransferase 
and elongation factors Tu and Ts, in biocide tolerance (Sampathkumar et al., 2004). Clp protease is a periplasmic 
chaperone protein that plays a major role for bacterial survival under stress conditions where proteins tend to 
unfold and aggregate (dos Santos et al., 2010; Frees et al., 2004). ClpP was found to be up-regulated in both WT15 
and MT51 upon chlorhexidine treatment, though the induction level of ClpP was higher at both concentrations in 
MT15 biofilms. In Staphylococcus aureus, Clp ATPases are required for stress tolerance against a broad range of 
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inducing factors (Frees et al., 2004). Induction of this protease upon chlorhexidine treatment indicates an effect on 
periplasmic proteins in order to decrease the toxic effect of misfolded proteins. However, the small heat shock 
protein, HSP 20, which is an ATP-independent molecular chaperone, was down-regulated by nearly 7-fold in 
WT15 chlorhexidine-treated biofilms, indicating this protein did not play a significant role in chlorhexidine 
tolerance (Vetura et al., 2007). Superoxide dismutase was also down-regulated in WT15 biofilms or not changed 
significantly in mutant biofilms, suggesting the absence of oxidative stress during chlorhexidine exposure. Other 
studies have made similar findings using different antimicrobial agents (dos Santos et al., 2010). The lack of 
oxidative stress is further substantiated by the down-regulation or absence of change in the hypothetical protein 
(alkylhydroperoxidase-like protein, AhpD family) and redoxin domain-containing protein that may have a role in 
attenuating the oxidative stress caused by peroxides and other reactive oxygen species (Hillas et al., 2000). 
Seemingly, the down-regulation of these proteins seemingly not be necessary to combat chlorhexidine stress may 
reflect the balanced utilisation of useful proteins to overcome chlorhexidine stress. 
The DIGE data also suggests the possibility of detoxification or degradation of chlorhexidine by 
amidohydrolases. The amidohydrolase superfamily is functionally-diverse, metal-dependent proteins that contain a 
triosephosphate isomerase (TIM)-like barrel fold in their catalytic domains (Aimin et al., 2007). They are 
important for amino acid and nucleotide metabolism, as well as biodegradation of industrial compounds, chemicals 
and pesticides. Although chlorhexidine treatment resulted in an increase in amidohydrolase abundance by 2-fold in 
both WT15 and MT51 biofilms (including proteins involved in protein synthesis, folding and stabilisation, such as 
GroEL, ClpP protease, aspartyl/glutamyl-tRNA amidotransferase, elongation factors Tu and Ts), chlorhexidine 
degradation studies using 14C-radiolabelled chlorhexidine demonstrated that WT15 could not mineralize 
chlorhexidine (Rema et al., 2014), though chlorhexidine degradation by other bacterial species is known (Tanaka et 
al., 2005). 
A few proteins associated with energy production, nucleotide transport and metabolism were also found to 
be up-regulated (Table 4.3) in the presence of chlorhexidine. Their increase in abundance may be due to the higher 
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energy demand for energy-dependent mechanisms of detoxification or adaptation to chlorhexidine. These proteins 
were also found to be more abundant in B. cenocepacia that was highly resistant to different classes of 
antimicrobials (Madeira et al., 2011).  
Consistent with the observed shift in fatty acid composition, several enzymes associated with fatty acid 
synthesis and metabolic processes (Table 4.3) were affected by chlorhexidine treatment in both strains. 
Microorganisms often adapt to environmental stress by changing the type and composition of membrane fatty acids 
(Sinensky, 1974) and the induction of these enzymes in D. acidovorans biofilms suggests this as a contributing 
adaptation mechanism to chlorhexidine. For example, increased expression of malonyl-CoA: ACP transacylase 
indicates increased fatty acid synthesis, which means increased consumption of acetyl-CoA as malonyl-CoA is 
derived from acetyl-CoA in the first step of fatty acid synthesis (Tong, 2005; Pyla et al., 2010). Consumption of 
acetyl-CoA for such purposes would decrease the production of poly-β-hydroxybutyrate (PHB) in PHB-producing 
organisms such as D. acidovorans (Sudesh et al., 1999), consistent with the observed decreased expression of 
phasin proteins which are known to be produced only during production of PHB (York et al., 2002).   
There is also a convincing indication of the involvement of several membrane proteins in chlorhexidine 
tolerance in D. acidovorans biofilms. A basic membrane lipoprotein (spot no. 371, Table 4.3), which is an outer 
membrane protein, was highly up-regulated in both WT15 and MT51 chlorhexidine-treated biofilms. Bacterial 
lipoproteins are known to have many functions, some of which include transport, signaling, antibiotic resistance, 
conjugation, protein secretion. Their involvement in microbial antibiotic resistance has been reported previously 
(Burns et al., 1996; Chang et al., 2012). A possible role for quorum sensing in the response to chlorhexidine is also 
suggested due to the down-regulation of the two-component LuxR family transcriptional regulator, especially in 
WT15 biofilms treated with chlorhexidine.   
The DIGE analysis indicates that overall chlorhexidine tolerance in D. acidovorans is an outcome of the 
effects of various antimicrobial resistance mechanisms at the molecular level, as has previously been reported for 
triclosan resistance in Salmonella enterica serovar Typhimurium (Weber et al., 2008). Of these, stress proteins, 
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chaperones and proteins involved in fatty acid metabolic processes, and possibly in membrane stability, appear to 
play a very important role in chlorhexidine tolerance in D. acidovorans biofilms. 
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5. GENERAL DISCUSSIONS AND CONCLUSION 
 
Microorganisms can become 1000 times more resistant to antimicrobials when they grow as biofilms 
(Tremblay et al., 2014). This becomes even more concerning when environmental microorganisms such as D. 
acidovorans that have been reported to be opportunistic pathogens are linked to antimicrobial resistance 
phenomena with limited data available on the actual mechanisms providing this enhanced tolerance. Delftia 
acidovorans is a Gram negative bacteria ubiquitously found in soil and water and has been associated with serious 
human infections (Cho and Lee, 2002; Perla and Kuntson, 2005) and infections associated with hospital devices 
(Weinstein et al., 1976; Mino et al., 2000; Kawamura et al., 2011). Several studies using D. acidovorans have 
reported their antimicrobial resistance capabilities against commonly-used antibiotics (Kawamura et al., 2011; 
Kam et al., 2012; Khan et al., 2012).   Among biocides, chlorhexidine (CHX) is considered the gold standard 
against which other antibacterial and antiplaque agents are assessed (Mathur et al., 2011). Several microorgansims 
have been found to be resistant to CHX (Stickler and Thomas (1980); Stickler, 2002); however, the exact 
mechanisms of CHX resistance are still not completely understood. 
Various studies have shown that physiological mechanisms tend to operate in concert at different 
hierarchical levels, many times synergistically, in order to confer enhanced tolerance in biofilms exposed to any 
environmental stress factor (Mah and O’Toole, 2001; Szomolay et al., 2005; Mangalappalli-Illathu and Korber, 
2006). The adaptive or tolerance mechanisms to these stresses reportedly vary from cell-surface changes, cellular 
morphological modification, production of degradative enzymes or efflux proteins, alterations in cellular fatty acid 
composition, induction of other stress response proteins and formation of persister cells (Braga and Ricci, 1998; 
Szomolay et al., 2005; Mangalappalli-Illathu and Korber, 2006). The research described in my thesis examined the 
effect of CHX on D. acidovorans biofilms at different concentrations, and is an attempt to gain knowledge about 
the underlying mechanisms that are involved in antimicrobial tolerance in this organism. I also further attempted to 
examine the role of a membrane protein, TolQ, in CHX tolerance in D. acidovorans biofilms. A deeper 
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mechanistic understanding will help in the development of compounds or other strategies that can interfere with 
antimicrobial tolerance development, and thus make Delftia biofilms susceptible to conventional antimicrobial 
compounds, enable the removal of biofilms in environmental settings and successful treatment of a variety of 
infections caused by these biofilm-forming bacteria. Broadly, some of the antimicrobial mechanisms shown to 
operate in microbial biofilms include: a) explusion of the agent by efflux systems, b) degradation, c) persister cell 
formation, d) penetration failure of the agent either due to altered cell membrane or biofilm properties etc. 
In this research work, I used a strain of D. acidovorans that was isolated from a river source and had a CHX 
MIC of 15 µg ml-1 and was considered to be CHX tolerant (WT15). To my knowledge, this is the first report of D. 
acidovorans tolerance to a broad spectrum biocide such as CHX (Rema et al., 2014) and adds to our knowledge 
regarding antimicrobial resistance a critical issue with regard to emerging environmental pathogens.  This study 
further demonstrates that antimicrobial resistance among microbial species is environmentally relevant and is not 
just an issue in hospital settings. This study also provides an appropriate example for the development of tolerance 
in biofilms in not just commonly-encountered pathogens such as E. coli, Salmonella, Listeria, etc. and that 
tolerance may be found in emerging pathogens and other bacterial species that have received less attention by 
microbiologists. Strain WT15 readily formed biofilms with very minimal nutrient media (1% TSB) and could 
tolerate above MIC levels of CHX (30 µg ml-1), as demonstrated in the studies published in Rema et al. (2014). 
This is in part due to the biofilm mode of growth providing increased tolerance to antimicrobials. Undoubtedly, 
this phenomenon is a serious concern with significant practical implications for the control of biofilms in 
healthcare facilities, households, food and other industries as routine cleaning procedures fail to eradicate them 
completely. 
A CHX-susceptible strain MT51 (MIC-1 µg ml-1) created by insertional mutation at the 81st bp of the tolQ 
gene indicated the putative role of this membrane protein in CHX tolerance in D. acidovorans. CHX is a 
membrane-active agent and mutation of a membrane protein (TolQ) that increased the susceptibility of D. 
acidovorans to CHX clearly points to a role of the cell membrane in CHX tolerance. Mutations in tol genes have 
previously been shown to confer hypersensitivity to various other agents, including detergents, quaternary 
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compounds, and some antibiotics in E. coli. This was further supported by the CLSM data that used fluorescent 
live-dead staining to demonstrate the effect of CHX based on the membrane permeability of CHX-susceptible and 
CHX-tolerant strains (Rema et al., 2014).  The uptake levels of CHX also varied between these strains as CHX was 
shown to accumulate to a greater extent inside CHX-susceptible mutant cells than in CHX-tolerant cells, as shown 
by STXM and IR analysis (Rema et al., 2014). The cell membrane is the first barrier to entry of antimicrobial 
agents and any entry into the cells indicates the cell membrane has somehow been breached. The observation of 
two different cell types within WT15 biofilms, one that apparently does not, or only slowly, takes-up CHX relative 
to the other (Rema et al., 2014) may indicate the existence of a “persister cells” within these biofilms and needs 
further validation. Ethylenediaminetetraacetic acid (EDTA) the outer membrane permeability of Gram negative 
bacteria by sequestering di- and multi-valent cations, and was shown to promote bioaccumulation of CHX in 
Delftia biofilms. Disruptions in cell membrane of cells exposed to CHX were also observed by TEM. Thus, all 
these studies point to the cell membrane as having a key role in CHX tolerance. 
Further, to my knowledge this study is also the first to investigate global changes in protein expression 
patterns of D. acidovorans under the influence of CHX. As reported in several other proteomic stress-response 
studies, my research also showed that bacterial environmental stress response is a coordinated, pan-metabolic 
outcome of the expression of a variety of genes that alter various cellular processes (cell division, DNA 
metabolism, housekeeping, membrane composition, transport, etc.). Numerous protein species-abundance changes 
in both CHX-tolerant WT15 and CHX-susceptible MT51 biofilms were seen when exposed to sub-MIC (10 µg ml-
1) and above-MIC (30 µg ml-1) levels of CHX. These changes were predominantly greater in CHX-treated mutant 
biofilms than the wild type biofilms, indicating some of involvment of tolQ in CHX tolerance. Gene ontology 
analysis revealed the collective participation of a wide range of key enzymes and proteins in CHX tolerance. These 
molecules were mainly involved in energy, nucleotide, fatty acid and amino acid metabolism, protein translation 
and modification, DNA binding and transcription, cell membrane-related functions and other cellular processes 
such as detoxification and stress response.  
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Overall, a multi-faceted, pan-metabolic response to CHX appears to exist in D. acidovorans biofilm cells 
(cellular detoxification, fatty acid and proteome modifications, synthesis of various bacterial stress response 
proteins, etc.), but primarily appears to be the cell envelope that ultimately influences the inhibition of D. 
acidovorans species by CHX. These stress responses may help the D. acidovorans biofilms to enhance their ability 
for survival in the nature and have a great significance especially if formed in critical environments such as 
healthcare facilities, the food industry, and households. There is further need to improve our understanding of the 
key factors influencing these enhanced tolerance mechanisms in order to develop effective control strategies in the 
future. 
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6. POSSIBLE FUTURE STUDIES 
 
My thesis research offers intial insights into biofilm development by Delftia acidovorans and the role of 
tolQ and the cell membrane in CHX tolerance. The stress response of D. acidovorans biofilms challenged with 
CHX was also examined at the molecular level and revealed that several proteins involved in various biological 
processes contributed to overall CHX tolerance.  However, due to certain limitations and scope of the work, there 
are still some areas that could be further investigated for a better understanding of CHX tolerance in 
microorganisms. These include: 
1. Most of the data on CHX-resistant microorganisms is associated with clinical specimens; however, the 
problem is seemingly more widespread than currently believed. More data on the prevalence of CHX-resistant 
microorganisms in environments, other than those from clinical settings, are needed to more fully appreciate this 
reality as this, in turn, may impact the health of living beings and may be a contributing factor for further cross 
resistance as reported in case of some commonly used antibiotics and other biocides. 
2. Apart from those used in this study, there may be other growth conditions that may enhance biofilm 
development in D. acidovorans and further increase CHX tolerance. Some examples include the availability of 
nutrients in media, media flow rate, type of substratum, age or thickness of biofilm before CHX exposure, etc. 
3. A more detailed molecular characterization of the role of tolQ gene in CHX resistance in the D. 
acidovorans strains used in my study is needed to provide further insights into the CHX tolerance mechanism. The 
interaction of TolQ with other tol proteins also needs to be elucidated. This may also help to determine the effect of 
tolQ on other proteins that were differentially-expressed between the wild type and mutant strains when exposed to 
CHX. 
4. It would be very interesting to see whether the two cell populations identified using STXM in CHX 
tolerant biofilms can be isolated and studied to confirm if CHX tolerance was a result of persister cell formation. A 
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correlative microscopic approach applying CLSM and STXM could be undertaken to see whether these two cell 
populations are the result of the status of membrane integrity in these cells. 
5. Both FAME and DIGE analysis indicated that fatty acid metabolism or pathways were altered in CHX-
exposed Delftia biofilms. Further investigation in this area, particularly examining the role of cyclic fatty acids in 
CHX tolerance, may be worthwhile as these fatty acids have been found to play an important role in bacterial stress 
response. 
6. Due to the high cost involved in protein identification, I was limited to the identification of only 40 
proteins that were differentially-expressed and thus my study may have missed reporting other proteins, or groups 
of proteins, that may be biologically-relevant to CHX tolerance. Many of the differentially expressed proteins can 
be further studied individually to understand their actual role in CHX tolerance in Delftia biofilms such as Clp 
protease, basic membrane lipoprotein, TauD and LuxR and based on that the actual mechanism of CHX tolerance 
can be narrowed down for example, efflux/ detoxification or fatty acid changes. Advanced gel free proteomic mass 
spectrometric techniques could be employed to comprehensively identify either the whole cell proteome or more 
specifically the membrane proteins to save time and to eliminate enrichment procedures. 
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